data_1iym_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iym _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.787 0.803 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.442 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE1' ' A' ' 158' ' ' HIS . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.46 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.661 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.3 m170 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 155' ' ' HIS . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.557 ' CE1' HD21 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.707 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.644 ' O ' ' N ' ' A' ' 168' ' ' SER . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.492 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 170' ' ' SER . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.707 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.661 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 41.3 mt . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.592 0.711 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.442 HD23 ' CE1' ' A' ' 158' ' ' HIS . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.57 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.53 HD11 ' CB ' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.616 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.599 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.3 m170 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 155' ' ' HIS . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.544 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.547 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.695 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.53 ' CB ' HD11 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.616 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 39.5 mt . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.533 0.683 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.475 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.475 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.511 ' CD2' ' HB1' ' A' ' 147' ' ' ALA . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.524 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.627 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.0 m170 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.427 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 155' ' ' HIS . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.533 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.699 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.465 ' O ' HD22 ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 170' ' ' SER . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.699 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.627 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 41.9 mt . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.457 ' O ' HD21 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.473 ' CD2' ' HB1' ' A' ' 147' ' ' ALA . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.526 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.638 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 22.1 m170 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.608 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.537 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.679 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.679 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 176' ' ' ARG . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.638 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 34.9 mt . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.649 0.737 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.407 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 24.9 m170 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.538 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.563 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 162' ' ' VAL . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' A' ' 168' ' ' SER . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.528 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.468 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 8.9 mt . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.677 0.751 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 147' ' ' ALA . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.681 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.1 m170 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.604 ' CE2' ' HG2' ' A' ' 173' ' ' PRO . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.546 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.695 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.461 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.681 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.69 0.757 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.445 HD22 ' CE1' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.682 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.4 m170 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE2' ' HG2' ' A' ' 173' ' ' PRO . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.544 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.557 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 159' ' ' ALA . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.705 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' SER . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.474 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 170' ' ' SER . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.587 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.682 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.748 0.785 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.438 ' O ' HD23 ' A' ' 138' ' ' LEU . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 134' ' ' CYS . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.504 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.673 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 27.3 m170 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.692 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.692 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.673 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.597 0.713 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.457 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.699 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 22.7 m170 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.545 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.542 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 162' ' ' VAL . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.719 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.645 ' O ' ' N ' ' A' ' 168' ' ' SER . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.531 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.484 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.464 HG21 ' O ' ' A' ' 170' ' ' SER . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.719 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.699 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.478 0.656 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.452 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.524 ' CB ' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.404 HD22 ' HB1' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.624 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 26.3 m170 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.529 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.553 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.632 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.501 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.52 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.524 HD13 ' CB ' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.624 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.7 mt . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.691 0.758 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' HB2' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.456 HD22 ' HB1' ' A' ' 147' ' ' ALA . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.539 HD12 ' CB ' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.628 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.2 m170 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.537 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.554 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.699 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.539 ' CB ' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.699 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.628 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 36.4 mt . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.731 0.777 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.618 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.3 m170 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.417 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.69 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 14.4 m-70 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.618 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.6 mt . . . . . 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.746 0.784 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.482 HD22 ' NE2' ' A' ' 158' ' ' HIS . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 158' ' ' HIS . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HD3' HG12 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.583 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 25.8 m170 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.621 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.542 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.557 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.721 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.602 ' O ' ' N ' ' A' ' 168' ' ' SER . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.511 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 11.4 m170 -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.48 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.721 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.597 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 9.1 mt . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.676 0.75 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.551 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' CB ' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.3 m170 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.551 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.707 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 168' ' ' SER . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.464 ' O ' HD22 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.479 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.707 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.584 ' CB ' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.672 0.749 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD2' HG12 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.661 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.1 m170 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 155' ' ' HIS . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.536 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' TRP . . . . . 0.721 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 168' ' ' SER . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.521 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' SER . . . . . 0.493 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.442 HG21 ' O ' ' A' ' 170' ' ' SER . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' CYS . . . . . 0.534 ' CB ' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . 0.721 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.661 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 38.4 mt . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -77.99 92.85 4.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.32 45.64 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.17 76.93 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.15 -133.29 1.94 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.28 100.1 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.22 135.13 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.327 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.522 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.442 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.442 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.557 HD21 ' CE1' ' A' ' 158' ' ' HIS . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.522 ' CD ' HG11 ' A' ' 179' ' ' VAL . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.661 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.589 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.3 m170 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.444 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.589 ' CE2' ' HB3' ' A' ' 155' ' ' HIS . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.557 ' CE1' HD21 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.707 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.644 ' O ' ' N ' ' A' ' 168' ' ' SER . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.458 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.492 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.52 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.707 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.661 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 41.3 mt -91.52 97.65 11.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.52 ' HA ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.98 154.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 110.265 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.522 HG11 ' CD ' ' A' ' 151' ' ' PRO . 2.3 t -100.79 -27.88 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 180' ' ' VAL . 6.1 m -79.62 150.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.457 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -175.07 4.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.11 108.49 1.55 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.434 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 2.8 p30 -136.56 62.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.298 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.26 -72.18 0.66 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 141' ' ' LEU . 60.0 t -119.16 112.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 109.598 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' OE2' ' HA ' ' A' ' 130' ' ' ASP . 6.3 mp0 -120.41 121.02 37.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.462 ' O ' ' HB2' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.5 ' CD1' HG12 ' A' ' 132' ' ' VAL . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.47 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.57 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.53 HD11 ' CB ' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.616 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.488 ' HB3' HD11 ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.488 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.599 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.3 m170 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.599 ' CE1' ' HB3' ' A' ' 155' ' ' HIS . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.544 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.547 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.695 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.53 ' CB ' HD11 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.616 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 39.5 mt -95.31 99.94 11.8 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.539 ' HA ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.89 154.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.401 HG12 ' HD3' ' A' ' 151' ' ' PRO . 1.6 t -81.69 -23.3 9.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.583 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.15 124.47 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.607 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.41 159.63 25.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.15 138.43 57.9 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.01 154.48 1.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.68 -68.93 0.53 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.543 ' CG1' ' CD1' ' A' ' 141' ' ' LEU . 90.1 t -59.91 122.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.339 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 132' ' ' VAL . 1.6 mp0 -143.24 122.65 13.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB3' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.475 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.475 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.543 ' CD1' ' CG1' ' A' ' 132' ' ' VAL . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.527 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.524 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.528 ' CD ' HG11 ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.627 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.609 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.0 m170 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.427 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE1' ' HB3' ' A' ' 155' ' ' HIS . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.533 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.699 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.465 ' O ' HD22 ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.473 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.524 ' SG ' ' CD1' ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.699 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.455 HD13 ' HB3' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.627 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 41.9 mt -94.66 101.41 13.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.527 ' HA ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.99 155.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.192 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.528 HG11 ' CD ' ' A' ' 151' ' ' PRO . 11.2 t -99.94 -39.5 7.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.308 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m -77.68 166.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.322 -0.861 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 99.3 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.519 179.963 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.1 tpp -178.65 78.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.89 173.16 1.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -99.5 90.62 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.34 -144.17 7.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.445 HG11 ' CD1' ' A' ' 141' ' ' LEU . 4.3 t -83.72 97.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 150.36 30.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.457 ' O ' HD21 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.457 HD21 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.473 ' CD2' ' HB1' ' A' ' 147' ' ' ALA . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.531 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.533 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.526 ' CD1' ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.566 ' CD ' ' CG1' ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.638 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 22.1 m170 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.533 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.608 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.537 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.556 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.679 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.468 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.493 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 178' ' ' THR . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.526 ' SG ' ' CD1' ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.679 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.594 ' O ' ' HB2' ' A' ' 176' ' ' ARG . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.594 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.638 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 34.9 mt -90.43 103.25 15.96 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.507 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -41.82 155.22 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.156 -0.965 . . . . 0.0 110.455 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.566 ' CG1' ' CD ' ' A' ' 151' ' ' PRO . 1.7 t -111.9 -30.18 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.465 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.68 107.23 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 109.543 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.385 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 71.76 82.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.55 179.97 6.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.476 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.91 146.76 52.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 116.46 160.42 12.1 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.34 143.81 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.121 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -115.71 123.98 49.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.143 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.407 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.407 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.547 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.58 ' NE ' ' O ' ' A' ' 178' ' ' THR . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.476 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 24.9 m170 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.538 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.563 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.47 ' N ' HG13 ' A' ' 162' ' ' VAL . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.646 ' O ' ' N ' ' A' ' 168' ' ' SER . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.528 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.468 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.524 ' CG2' ' HB ' ' A' ' 178' ' ' THR . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.547 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.593 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 8.9 mt -79.75 94.79 5.82 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.58 ' O ' ' NE ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -46.33 144.28 2.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.692 -1.255 . . . . 0.0 109.484 -179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.404 HG22 ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -109.26 -16.37 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.321 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.53 116.57 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.885 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.529 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -129.04 142.26 50.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 109.96 2.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -100.4 156.25 17.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.96 -132.04 7.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 t -110.4 119.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.241 -1.152 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -104.18 121.61 43.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.385 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.459 HD23 ' HB2' ' A' ' 147' ' ' ALA . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.436 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.548 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.527 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.681 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.518 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.1 m170 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.604 ' CE2' ' HG2' ' A' ' 173' ' ' PRO . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.546 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.555 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.546 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.695 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.461 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.527 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.695 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.59 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.681 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt -94.86 91.3 6.37 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.48 153.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.597 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.475 ' CG1' ' CD ' ' A' ' 151' ' ' PRO . 1.2 t -116.72 -7.7 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.76 125.43 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.489 ' CG2' ' OXT' ' A' ' 181' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' O ' ' OD2' ' A' ' 130' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.56 -173.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.328 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -54.66 117.74 3.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.447 ' OD2' ' O ' ' A' ' 127' ' ' ALA . 21.4 p30 -172.89 165.22 5.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -122.37 -121.73 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.15 118.69 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -1.131 . . . . 0.0 109.391 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 130' ' ' ASP . 2.4 mp0 -105.76 133.13 50.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.96 . . . . 0.0 110.147 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.445 HD22 ' CE1' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.412 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.569 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.532 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.682 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.52 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.4 m170 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE2' ' HG2' ' A' ' 173' ' ' PRO . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.544 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.557 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.443 ' OD2' ' O ' ' A' ' 159' ' ' ALA . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.705 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.648 ' O ' ' N ' ' A' ' 168' ' ' SER . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.474 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.705 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.587 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.682 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt -89.79 91.77 8.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.532 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -41.6 154.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.517 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.472 HG11 ' CG ' ' A' ' 151' ' ' PRO . 1.5 t -116.78 -6.03 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.43 146.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.45 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 128' ' ' MET . 2.0 ptp -136.42 98.79 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.37 143.92 26.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.73 105.84 7.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.88 -129.64 6.88 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.403 HG11 ' N ' ' A' ' 133' ' ' GLU . 43.1 t -119.75 158.43 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' N ' HG11 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.291 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.438 ' O ' HD23 ' A' ' 138' ' ' LEU . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 134' ' ' CYS . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.403 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.504 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.52 ' CD ' HG11 ' A' ' 179' ' ' VAL . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.673 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.516 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 27.3 m170 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.504 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.605 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.692 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.529 ' CG2' ' HB ' ' A' ' 178' ' ' THR . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.692 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.588 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.673 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.1 mt -94.29 88.52 5.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.65 150.52 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.543 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.52 HG11 ' CD ' ' A' ' 151' ' ' PRO . 1.4 t -101.98 -33.32 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 109.091 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.99 167.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 O-C-N 121.331 -0.855 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 181' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.534 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.77 52.77 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.23 97.77 7.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.43 65.33 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.414 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.83 166.52 24.25 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.26 123.03 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -1.183 . . . . 0.0 109.495 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.22 122.34 33.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.41 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HB3' ' CD1' ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.446 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.446 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.51 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.544 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.528 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.508 ' CD ' HG12 ' A' ' 179' ' ' VAL . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.699 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.534 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.61 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 22.7 m170 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.545 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.544 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.542 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.435 ' N ' ' CG1' ' A' ' 162' ' ' VAL . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.719 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.645 ' O ' ' N ' ' A' ' 168' ' ' SER . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.531 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.484 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.719 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.496 ' CD1' ' HB3' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.699 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt -87.49 91.46 8.74 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HA ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.17 154.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.508 HG12 ' CD ' ' A' ' 151' ' ' PRO . 1.1 t -121.84 -12.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.83 . . . . 0.0 109.368 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.6 m -78.3 166.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.403 179.928 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.299 0.571 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -140.51 -179.84 6.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.407 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.32 84.37 5.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.229 -0.919 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.8 140.16 57.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.23 -79.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.94 133.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -1.159 . . . . 0.0 109.349 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -125.66 122.63 36.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.452 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.524 ' CB ' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.553 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.404 HD22 ' HB1' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.497 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.624 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.601 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 26.3 m170 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.601 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.529 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.553 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.632 ' O ' ' N ' ' A' ' 168' ' ' SER . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.501 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.52 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 178' ' ' THR . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.535 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.524 HD13 ' CB ' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.624 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.7 mt -93.29 106.05 18.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.501 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -42.04 155.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.45 HG12 HD21 ' A' ' 150' ' ' LEU . 1.1 t -92.98 -44.26 13.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.351 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.0 m -76.98 152.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.44 ' OXT' ' CG1' ' A' ' 181' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.415 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mtt 52.28 -174.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.27 176.54 7.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.206 -0.934 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.45 176.73 5.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.855 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.64 -108.16 0.25 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 133' ' ' GLU . 32.1 t -83.89 148.28 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -1.196 . . . . 0.0 109.441 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.466 ' N ' HG11 ' A' ' 132' ' ' VAL . 0.7 OUTLIER -130.91 147.91 52.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.554 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' HB2' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.456 HD22 ' HB1' ' A' ' 147' ' ' ALA . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.536 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.539 HD12 ' CB ' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.485 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.628 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.484 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.2 m170 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.537 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.554 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.699 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.465 ' HA ' HD23 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.518 ' CG2' ' HB ' ' A' ' 178' ' ' THR . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.539 ' CB ' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.699 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.628 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 36.4 mt -96.77 98.22 9.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.518 ' HB ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.05 154.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.922 . . . . 0.0 110.271 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.485 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.7 t -90.47 -46.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.268 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.01 153.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.257 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -160.35 64.73 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.359 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.81 76.61 8.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.689 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -75.47 97.73 3.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.47 -175.27 0.1 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.51 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.423 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.62 122.67 47.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.443 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.552 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.465 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.529 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.618 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.487 ' HB3' HD11 ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.465 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.3 m170 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.508 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.417 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.552 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.69 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 14.4 m-70 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.529 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.69 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.618 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.6 mt -94.96 103.66 15.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.493 ' O ' ' HD2' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -42.14 155.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.075 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.415 HG13 HD22 ' A' ' 150' ' ' LEU . 1.5 t -87.54 -49.19 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.98 151.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.47 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 ttt -156.42 69.19 0.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -101.01 116.46 32.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -77.16 93.54 3.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.407 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.02 -178.65 45.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.569 ' CG1' ' CD1' ' A' ' 141' ' ' LEU . 40.0 t -89.24 95.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -135.06 120.1 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.484 ' CB ' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.557 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.569 ' CD1' ' CG1' ' A' ' 132' ' ' VAL . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 158' ' ' HIS . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HD3' HG12 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.531 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.592 ' NE ' ' O ' ' A' ' 178' ' ' THR . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.472 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.596 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 25.8 m170 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.621 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.542 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.557 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.721 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.602 ' O ' ' N ' ' A' ' 168' ' ' SER . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.511 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 11.4 m170 -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.48 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.533 ' CG2' ' HB ' ' A' ' 178' ' ' THR . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.721 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.484 HD13 ' CB ' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.597 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 9.1 mt -82.56 94.23 7.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.592 ' O ' ' NE ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -44.9 142.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.833 -1.167 . . . . 0.0 109.36 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -5.78 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.74 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.43 121.54 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.164 -0.96 . . . . 0.0 109.491 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.432 ' O ' HG11 ' A' ' 181' ' ' VAL . 13.7 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.475 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER 47.44 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD2' ' OE2' ' A' ' 133' ' ' GLU . 1.7 m-20 -58.79 112.43 1.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.282 -0.886 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 128' ' ' MET . 4.2 m-20 -98.52 40.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.453 ' O ' ' OE1' ' A' ' 133' ' ' GLU . . . 118.77 -151.9 17.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.96 140.88 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.371 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 131' ' ' GLY . 0.3 OUTLIER -112.1 142.23 44.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.943 . . . . 0.0 110.194 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.551 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.47 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.584 ' HD3' ' CB ' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.3 m170 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.551 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.707 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.651 ' O ' ' N ' ' A' ' 168' ' ' SER . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.464 ' O ' HD22 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.498 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.522 ' CG2' ' HA ' ' A' ' 178' ' ' THR . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.525 ' HB2' ' CD1' ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.707 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.595 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.584 ' CB ' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt -78.0 92.46 4.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.555 ' O ' ' NE ' ' A' ' 152' ' ' ARG . 0.1 OUTLIER -44.61 146.23 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.898 -1.126 . . . . 0.0 109.771 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.51 -15.79 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.606 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 0.1 OUTLIER -109.87 109.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.455 ' OXT' HG11 ' A' ' 181' ' ' VAL . 14.9 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.438 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 67.84 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.7 114.37 21.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 130' ' ' ASP . 21.5 t0 -126.24 133.92 51.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.12 -49.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.91 137.23 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.51 141.28 51.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -0.967 . . . . 0.0 110.169 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.444 ' HD2' HG12 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.545 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.534 HD12 ' CB ' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.448 ' CD ' ' CG1' ' A' ' 179' ' ' VAL . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.661 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.489 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.602 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.1 m170 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.602 ' CE2' ' HB3' ' A' ' 155' ' ' HIS . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.536 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.541 ' CB ' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.548 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HA ' HD11 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' TRP . . . . . 0.721 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.641 ' O ' ' N ' ' A' ' 168' ' ' SER . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.521 ' O ' ' CD2' ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' SER . . . . . 0.493 ' HA ' HD23 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.532 ' CG2' ' HB ' ' A' ' 178' ' ' THR . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' CYS . . . . . 0.534 ' CB ' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.721 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.661 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 38.4 mt -91.97 94.47 9.3 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.95 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.199 -179.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.448 ' CG1' ' CD ' ' A' ' 151' ' ' PRO . 2.5 t -98.49 -26.63 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.269 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.87 146.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 53.2 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.95 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.787 0.803 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 1.069 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 147' ' ' ALA . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.698 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.676 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.615 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 33.5 m-70 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.632 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.68 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.61 ' HA ' HD12 ' A' ' 166' ' ' LEU . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.852 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.958 ' HB2' HD12 ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.72 ' SG ' HD12 ' A' ' 177' ' ' LEU . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.72 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.3 mt . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.592 0.711 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.451 ' C ' ' HG ' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.875 HD23 ' NE2' ' A' ' 158' ' ' HIS . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.588 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.895 HD12 ' HB2' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.643 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 37.0 m-70 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.588 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.643 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.875 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.704 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.895 ' HB2' HD12 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.704 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 39.5 mt . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.533 0.683 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 156' ' ' GLY . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.777 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 36.3 m-70 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.58 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.709 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.9 mt . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.501 ' O ' HD23 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 156' ' ' GLY . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.628 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 28.9 m-70 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.63 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.661 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.687 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' O ' HD23 ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.498 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.687 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.729 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.729 HD12 ' SG ' ' A' ' 175' ' ' CYS . 34.9 mt . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.649 0.737 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.708 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.572 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 134' ' ' CYS . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD2' ' HA3' ' A' ' 156' ' ' GLY . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.615 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.468 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 32.1 m-70 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.726 ' HA ' HD12 ' A' ' 166' ' ' LEU . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.733 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.733 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 175' ' ' CYS . 8.9 mt . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.677 0.751 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.586 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.487 HD23 ' NE2' ' A' ' 158' ' ' HIS . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.429 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.697 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 31.7 m-70 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.627 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.549 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.568 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.703 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.893 ' HB2' HD12 ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.703 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.697 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.69 0.757 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.621 HD23 ' NE2' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.951 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.909 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.704 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.515 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 29.2 m-70 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.621 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.645 ' HA ' HD12 ' A' ' 166' ' ' LEU . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.714 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 169' ' ' HIS . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.738 ' O ' HD23 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.909 ' HB2' HD12 ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.714 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HB2' ' A' ' 135' ' ' ALA . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.704 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.748 0.785 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.519 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.689 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 37.5 m-70 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.702 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.913 ' HB2' HD12 ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.702 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.597 0.713 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.569 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 147' ' ' ALA . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HD3' HG11 ' A' ' 162' ' ' VAL . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.709 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.5 m-70 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.599 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 166' ' ' LEU . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.731 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 169' ' ' HIS . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.949 ' O ' HD23 ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.731 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.709 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.478 0.656 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.727 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.574 ' C ' HD23 ' A' ' 150' ' ' LEU . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.635 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 35.3 m-70 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.624 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.552 ' O ' HG12 ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.711 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 169' ' ' HIS . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.864 ' O ' HD23 ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.582 ' HA ' HD22 ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.711 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 40.7 mt . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.691 0.758 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.583 ' O ' HD23 ' A' ' 138' ' ' LEU . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 34.9 m-70 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.653 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.71 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.861 ' HB2' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.71 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.719 HD12 ' SG ' ' A' ' 175' ' ' CYS . 36.4 mt . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.731 0.777 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.971 ' O ' HD23 ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.633 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 33.7 m-70 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.56 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 9.1 m80 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.559 ' HA ' HD22 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.838 ' HB2' HD12 ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.73 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.6 mt . . . . . 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.746 0.784 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 147' ' ' ALA . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.831 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HD3' HG11 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' C ' HD23 ' A' ' 150' ' ' LEU . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 34.4 m-70 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.831 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.855 ' HA ' HD12 ' A' ' 166' ' ' LEU . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.85 ' HB2' HD12 ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 175' ' ' CYS . 9.1 mt . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.676 0.75 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 147' ' ' ALA . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.879 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.626 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 39.9 m-70 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.638 ' HA ' HD12 ' A' ' 166' ' ' LEU . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 169' ' ' HIS . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.808 ' O ' HD23 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.879 ' HB2' HD12 ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.612 ' SG ' HD12 ' A' ' 177' ' ' LEU . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.672 0.749 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.493 HD23 ' NE2' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.81 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.87 HD12 ' HB2' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.675 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 33.8 m-70 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.555 ' O ' HG12 ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 148' ' ' ARG . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' TRP . . . . . 0.734 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.896 ' O ' HD23 ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' CYS . . . . . 0.87 ' HB2' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . 0.734 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 38.4 mt . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -77.99 92.85 4.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.32 45.64 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.17 76.93 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.15 -133.29 1.94 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.28 100.1 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.22 135.13 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.327 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 1.069 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 147' ' ' ALA . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.698 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.896 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.676 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.615 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.3 m170 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.632 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.68 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.61 ' HA ' HD12 ' A' ' 166' ' ' LEU . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.852 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.925 HG22 ' HA ' ' A' ' 178' ' ' THR . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.958 ' HB2' HD12 ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.72 ' SG ' HD12 ' A' ' 177' ' ' LEU . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.72 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.3 mt -91.52 97.65 11.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.925 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.98 154.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 110.265 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.896 HG13 ' CD ' ' A' ' 151' ' ' PRO . 2.3 t -100.79 -27.88 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.1 m -79.62 150.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.457 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -175.07 4.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.11 108.49 1.55 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.443 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 2.8 p30 -136.56 62.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.298 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.26 -72.18 0.66 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.595 HG12 HD11 ' A' ' 141' ' ' LEU . 60.0 t -119.16 112.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 109.598 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 130' ' ' ASP . 6.3 mp0 -120.41 121.02 37.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.451 ' C ' ' HG ' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.875 HD23 ' NE2' ' A' ' 158' ' ' HIS . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.588 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.895 HD12 ' HB2' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.643 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.3 m170 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.588 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.643 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.875 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.704 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 1.003 HG22 ' HA ' ' A' ' 178' ' ' THR . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.895 ' HB2' HD12 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.704 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 39.5 mt -95.31 99.94 11.8 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 1.003 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.89 154.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 150' ' ' LEU . 1.6 t -81.69 -23.3 9.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.583 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.15 124.47 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.607 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.41 159.63 25.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.15 138.43 57.9 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.01 154.48 1.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.68 -68.93 0.53 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.917 ' CG1' HD12 ' A' ' 141' ' ' LEU . 90.1 t -59.91 122.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.339 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 132' ' ' VAL . 1.6 mp0 -143.24 122.65 13.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.917 HD12 ' CG1' ' A' ' 132' ' ' VAL . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.777 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.787 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.0 m170 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.58 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.963 HG22 ' HA ' ' A' ' 178' ' ' THR . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.709 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.9 mt -94.66 101.41 13.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.963 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.99 155.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.192 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.787 HG13 ' CD ' ' A' ' 151' ' ' PRO . 11.2 t -99.94 -39.5 7.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.308 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m -77.68 166.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.322 -0.861 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.453 ' OXT' HG12 ' A' ' 181' ' ' VAL . 99.3 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.1 tpp -178.65 78.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.89 173.16 1.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -99.5 90.62 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.34 -144.17 7.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' CD1' ' A' ' 141' ' ' LEU . 4.3 t -83.72 97.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 150.36 30.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.501 ' O ' HD23 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 132' ' ' VAL . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.955 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.628 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 22.1 m170 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.63 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.661 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.687 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' O ' HD23 ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.498 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' THR . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.687 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.729 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.729 HD12 ' SG ' ' A' ' 175' ' ' CYS . 34.9 mt -90.43 103.25 15.96 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.675 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.82 155.22 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.156 -0.965 . . . . 0.0 110.455 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.955 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.7 t -111.9 -30.18 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.465 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.68 107.23 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 109.543 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.385 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 71.76 82.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.55 179.97 6.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.476 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.91 146.76 52.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 116.46 160.42 12.1 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.34 143.81 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.121 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -115.71 123.98 49.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.143 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.708 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.572 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 134' ' ' CYS . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD2' ' HA3' ' A' ' 156' ' ' GLY . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.615 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.468 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 24.9 m170 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.726 ' HA ' HD12 ' A' ' 166' ' ' LEU . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.733 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' THR . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.733 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 175' ' ' CYS . 8.9 mt -79.75 94.79 5.82 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.81 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -46.33 144.28 2.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.692 -1.255 . . . . 0.0 109.484 -179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.26 -16.37 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.321 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.53 116.57 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.885 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.529 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -129.04 142.26 50.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 109.96 2.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -100.4 156.25 17.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.96 -132.04 7.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 t -110.4 119.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.241 -1.152 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -104.18 121.61 43.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.385 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.586 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.487 HD23 ' NE2' ' A' ' 158' ' ' HIS . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.429 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.748 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.697 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.1 m170 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.627 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.549 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.568 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.703 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 178' ' ' THR . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.893 ' HB2' HD12 ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.703 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.697 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt -94.86 91.3 6.37 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.931 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.48 153.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.597 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.748 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.2 t -116.72 -7.7 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.76 125.43 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.703 ' OXT' HG22 ' A' ' 181' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.578 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.56 -173.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.328 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -54.66 117.74 3.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.578 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 21.4 p30 -172.89 165.22 5.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -122.37 -121.73 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.15 118.69 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -1.131 . . . . 0.0 109.391 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 130' ' ' ASP . 2.4 mp0 -105.76 133.13 50.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.96 . . . . 0.0 110.147 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.621 HD23 ' NE2' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.951 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.909 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.684 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.84 HH21 HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.515 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 23.4 m170 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.621 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.645 ' HA ' HD12 ' A' ' 166' ' ' LEU . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.714 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 169' ' ' HIS . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.738 ' O ' HD23 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 178' ' ' THR . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.909 ' HB2' HD12 ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.714 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HB2' ' A' ' 135' ' ' ALA . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.704 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt -89.79 91.77 8.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.898 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.6 154.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.517 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.684 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.5 t -116.78 -6.03 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.43 146.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.45 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 128' ' ' MET . 2.0 ptp -136.42 98.79 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.37 143.92 26.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.73 105.84 7.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.88 -129.64 6.88 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 133' ' ' GLU . 43.1 t -119.75 158.43 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.291 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.519 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.766 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.689 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 27.3 m170 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.702 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 178' ' ' THR . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.913 ' HB2' HD12 ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.702 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.1 mt -94.29 88.52 5.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.802 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.65 150.52 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.543 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.766 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.4 t -101.98 -33.32 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 109.091 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.99 167.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 O-C-N 121.331 -0.855 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 181' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.534 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.77 52.77 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.23 97.77 7.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.43 65.33 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.414 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.83 166.52 24.25 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' H ' ' A' ' 156' ' ' GLY . 3.2 t -91.26 123.03 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -1.183 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.22 122.34 33.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.41 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.569 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 147' ' ' ALA . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HD3' HG11 ' A' ' 162' ' ' VAL . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.614 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.709 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 22.7 m170 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.654 ' H ' HG11 ' A' ' 132' ' ' VAL . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.599 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 166' ' ' LEU . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.731 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 169' ' ' HIS . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.949 ' O ' HD23 ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.908 HG22 ' HA ' ' A' ' 178' ' ' THR . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.731 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.709 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt -87.49 91.46 8.74 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.908 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.17 154.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.614 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.1 t -121.84 -12.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.83 . . . . 0.0 109.368 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.6 m -78.3 166.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 181' ' ' VAL . 60.8 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.299 0.571 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -140.51 -179.84 6.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.407 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.32 84.37 5.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.229 -0.919 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.8 140.16 57.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.23 -79.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.94 133.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -1.159 . . . . 0.0 109.349 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -125.66 122.63 36.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.727 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.574 ' C ' HD23 ' A' ' 150' ' ' LEU . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.635 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 26.3 m170 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.624 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.552 ' O ' HG12 ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.711 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 169' ' ' HIS . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.864 ' O ' HD23 ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.582 ' HA ' HD22 ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 178' ' ' THR . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.711 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 40.7 mt -93.29 106.05 18.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.812 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.04 155.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.626 HG22 HD13 ' A' ' 150' ' ' LEU . 1.1 t -92.98 -44.26 13.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.351 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 180' ' ' VAL . 12.0 m -76.98 152.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.574 HG13 ' OXT' ' A' ' 181' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.415 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mtt 52.28 -174.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.27 176.54 7.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.206 -0.934 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.45 176.73 5.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.855 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.64 -108.16 0.25 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.1 t -83.89 148.28 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -1.196 . . . . 0.0 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.91 147.91 52.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.583 ' O ' HD23 ' A' ' 138' ' ' LEU . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.662 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.2 m170 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.653 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.71 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.894 HG22 ' CA ' ' A' ' 178' ' ' THR . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.861 ' HB2' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.71 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.719 HD12 ' SG ' ' A' ' 175' ' ' CYS . 36.4 mt -96.77 98.22 9.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.894 ' CA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.05 154.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.922 . . . . 0.0 110.271 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.741 HG22 HD13 ' A' ' 150' ' ' LEU . 1.7 t -90.47 -46.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.268 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.01 153.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.257 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -160.35 64.73 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.359 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.81 76.61 8.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.689 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -75.47 97.73 3.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.47 -175.27 0.1 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.51 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.423 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.62 122.67 47.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.971 ' O ' HD23 ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.633 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.3 m170 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.56 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 9.1 m80 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.559 ' HA ' HD22 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 178' ' ' THR . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.838 ' HB2' HD12 ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.73 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.6 mt -94.96 103.66 15.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.915 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.14 155.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.075 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 150' ' ' LEU . 1.5 t -87.54 -49.19 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.98 151.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.47 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 ttt -156.42 69.19 0.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -101.01 116.46 32.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -77.16 93.54 3.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.407 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.02 -178.65 45.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 1.097 ' CG1' HD12 ' A' ' 141' ' ' LEU . 40.0 t -89.24 95.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -135.06 120.1 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 1.097 HD12 ' CG1' ' A' ' 132' ' ' VAL . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.831 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HD3' HG11 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' C ' HD23 ' A' ' 150' ' ' LEU . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 25.8 m170 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.831 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.855 ' HA ' HD12 ' A' ' 166' ' ' LEU . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 0.6 OUTLIER -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.877 HG22 ' HA ' ' A' ' 178' ' ' THR . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.85 ' HB2' HD12 ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 175' ' ' CYS . 9.1 mt -82.56 94.23 7.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.877 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -44.9 142.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.833 -1.167 . . . . 0.0 109.36 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -5.78 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.74 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.43 121.54 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.164 -0.96 . . . . 0.0 109.491 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.475 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER 47.44 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD2' ' OE2' ' A' ' 133' ' ' GLU . 1.7 m-20 -58.79 112.43 1.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.282 -0.886 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 128' ' ' MET . 4.2 m-20 -98.52 40.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.453 ' O ' ' OE1' ' A' ' 133' ' ' GLU . . . 118.77 -151.9 17.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.96 140.88 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.371 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 131' ' ' GLY . 0.3 OUTLIER -112.1 142.23 44.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.943 . . . . 0.0 110.194 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 147' ' ' ALA . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.879 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.626 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.3 m170 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.638 ' HA ' HD12 ' A' ' 166' ' ' LEU . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 169' ' ' HIS . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.808 ' O ' HD23 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 178' ' ' THR . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.879 ' HB2' HD12 ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.612 ' SG ' HD12 ' A' ' 177' ' ' LEU . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt -78.0 92.46 4.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.817 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -44.61 146.23 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.898 -1.126 . . . . 0.0 109.771 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.444 HG22 ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -114.51 -15.79 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.606 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 0.1 OUTLIER -109.87 109.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.438 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 67.84 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.7 114.37 21.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 130' ' ' ASP . 21.5 t0 -126.24 133.92 51.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.12 -49.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.91 137.23 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.51 141.28 51.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -0.967 . . . . 0.0 110.169 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.493 HD23 ' NE2' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.81 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.87 HD12 ' HB2' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.93 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.679 HH21 HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.1 m170 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.555 ' O ' HG12 ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 148' ' ' ARG . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' TRP . . . . . 0.734 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.896 ' O ' HD23 ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.823 HG22 ' HB ' ' A' ' 178' ' ' THR . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' CYS . . . . . 0.87 ' HB2' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.734 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 38.4 mt -91.97 94.47 9.3 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.823 ' HB ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.95 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.199 -179.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.93 HG13 ' CD ' ' A' ' 151' ' ' PRO . 2.5 t -98.49 -26.63 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.269 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.87 146.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 181' ' ' VAL . 53.2 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.787 0.803 . . . . 0.0 110.327 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 1.069 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 147' ' ' ALA . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.698 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.676 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.615 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.3 m170 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.632 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.68 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.61 ' HA ' HD12 ' A' ' 166' ' ' LEU . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.852 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.958 ' HB2' HD12 ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.72 ' SG ' HD12 ' A' ' 177' ' ' LEU . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.72 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.3 mt . . . . . 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.592 0.711 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.451 ' C ' ' HG ' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.875 HD23 ' NE2' ' A' ' 158' ' ' HIS . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.588 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.895 HD12 ' HB2' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.643 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.3 m170 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.588 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.643 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.875 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.704 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.895 ' HB2' HD12 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.704 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 39.5 mt . . . . . 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.533 0.683 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.516 HD11 ' O ' ' A' ' 156' ' ' GLY . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.777 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.0 m170 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.58 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.709 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.9 mt . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.681 0.753 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.501 ' O ' HD23 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 156' ' ' GLY . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.628 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 22.1 m170 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.63 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.661 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.687 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.636 ' O ' HD23 ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.498 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.687 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.729 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.729 HD12 ' SG ' ' A' ' 175' ' ' CYS . 34.9 mt . . . . . 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.649 0.737 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.708 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.572 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 134' ' ' CYS . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD2' ' HA3' ' A' ' 156' ' ' GLY . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.615 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.468 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 24.9 m170 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.726 ' HA ' HD12 ' A' ' 166' ' ' LEU . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.733 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.733 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 175' ' ' CYS . 8.9 mt . . . . . 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.677 0.751 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.586 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.487 HD23 ' NE2' ' A' ' 158' ' ' HIS . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.429 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.697 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.1 m170 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.627 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.549 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.568 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.703 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.893 ' HB2' HD12 ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.703 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.697 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt . . . . . 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.69 0.757 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.621 HD23 ' NE2' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.951 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.909 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.503 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.704 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.515 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 23.4 m170 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.645 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.621 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.645 ' HA ' HD12 ' A' ' 166' ' ' LEU . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.714 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 169' ' ' HIS . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.738 ' O ' HD23 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.909 ' HB2' HD12 ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.714 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HB2' ' A' ' 135' ' ' ALA . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.704 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt . . . . . 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.748 0.785 . . . . 0.0 110.291 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.519 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.689 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 27.3 m170 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.702 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.913 ' HB2' HD12 ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.702 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.1 mt . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.597 0.713 . . . . 0.0 110.41 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.569 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 147' ' ' ALA . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HD3' HG11 ' A' ' 162' ' ' VAL . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.709 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 22.7 m170 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.599 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 166' ' ' LEU . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.731 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 169' ' ' HIS . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.949 ' O ' HD23 ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.731 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.709 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt . . . . . 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.478 0.656 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.727 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.574 ' C ' HD23 ' A' ' 150' ' ' LEU . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.635 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 26.3 m170 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.624 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.552 ' O ' HG12 ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.711 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 169' ' ' HIS . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.864 ' O ' HD23 ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.582 ' HA ' HD22 ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.711 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 40.7 mt . . . . . 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.691 0.758 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.583 ' O ' HD23 ' A' ' 138' ' ' LEU . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.647 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.2 m170 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.653 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.71 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.861 ' HB2' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.71 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.719 HD12 ' SG ' ' A' ' 175' ' ' CYS . 36.4 mt . . . . . 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.731 0.777 . . . . 0.0 110.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.971 ' O ' HD23 ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.633 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.3 m170 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.458 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.56 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 14.4 m-70 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.559 ' HA ' HD22 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.838 ' HB2' HD12 ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.73 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.6 mt . . . . . 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.746 0.784 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' A' ' 147' ' ' ALA . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.831 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HD3' HG11 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' C ' HD23 ' A' ' 150' ' ' LEU . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 25.8 m170 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.831 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.855 ' HA ' HD12 ' A' ' 166' ' ' LEU . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 11.4 m170 -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.85 ' HB2' HD12 ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 175' ' ' CYS . 9.1 mt . . . . . 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.676 0.75 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 147' ' ' ALA . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.879 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.626 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.3 m170 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.638 ' HA ' HD12 ' A' ' 166' ' ' LEU . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 169' ' ' HIS . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.808 ' O ' HD23 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.879 ' HB2' HD12 ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.612 ' SG ' HD12 ' A' ' 177' ' ' LEU . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.672 0.749 . . . . 0.0 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.493 HD23 ' NE2' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.81 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.87 HD12 ' HB2' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.675 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.1 m170 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.555 ' O ' HG12 ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 148' ' ' ARG . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' TRP . . . . . 0.734 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.896 ' O ' HD23 ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' CYS . . . . . 0.87 ' HB2' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . 0.734 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 38.4 mt . . . . . 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.413 ' O ' ' HG2' ' A' ' 128' ' ' MET . 0.0 OUTLIER -77.99 92.85 4.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.525 -179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -85.32 45.64 1.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.561 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -136.17 76.93 1.63 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.918 . . . . 0.0 109.486 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -152.15 -133.29 1.94 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.2 t -97.28 100.1 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.252 -1.146 . . . . 0.0 109.399 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.22 135.13 34.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 110.327 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 1.069 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.7 t -72.2 111.74 7.68 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.96 -8.66 23.92 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.076 -1.015 . . . . 0.0 109.628 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 87.4 t -98.85 -66.38 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.123 -0.986 . . . . 0.0 110.743 -179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -94.02 -15.1 25.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.699 -1.251 . . . . 0.0 110.171 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.5 mt 59.77 39.92 20.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.28 125.98 51.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.297 -0.877 . . . . 0.0 109.353 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -46.59 115.67 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.231 -0.918 . . . . 0.0 109.402 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' A' ' 147' ' ' ALA . 35.5 mt -58.68 107.26 0.49 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.519 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -113.01 173.61 6.3 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.229 -0.92 . . . . 0.0 109.537 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -70.38 147.55 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 109.636 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 112.35 -13.29 25.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -111.15 177.11 4.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.141 -1.211 . . . . 0.0 109.566 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.868 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 3.4 mm-40 -121.05 72.1 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.365 -0.834 . . . . 0.0 109.322 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.698 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.88 140.78 55.17 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.124 -0.985 . . . . 0.0 109.571 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -112.3 122.57 48.09 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.285 -0.884 . . . . 0.0 109.75 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 2.8 m-85 -98.73 147.15 25.17 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.836 . . . . 0.0 108.791 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.958 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.7 mt -99.03 158.72 31.81 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.804 -1.185 . . . . 0.0 109.931 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.896 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.5 Cg_endo -78.79 -43.31 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.864 2.376 . . . . 0.0 112.012 -178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.676 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.5 OUTLIER -52.26 -45.52 65.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.882 -1.137 . . . . 0.0 110.218 -178.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.97 -50.6 2.15 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.087 -0.645 . . . . 0.0 111.809 -176.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.49 -0.04 29.34 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.615 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.3 m170 -53.22 120.08 5.53 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.457 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -93.87 127.18 8.95 Favored Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.319 -1.419 . . . . 0.0 110.665 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.632 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 84.5 m-85 -123.54 -170.77 2.18 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.68 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.9 m80 -91.95 159.3 15.82 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.038 -1.039 . . . . 0.0 110.016 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.41 -28.17 60.96 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -84.09 -51.97 6.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.917 -0.49 . . . . 0.0 109.962 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.559 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 9.0 m -65.94 -40.45 91.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.561 HG12 ' O ' ' A' ' 158' ' ' HIS . 3.9 p -63.31 -26.96 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.656 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.61 ' HA ' HD12 ' A' ' 166' ' ' LEU . 16.1 m-20 -78.85 -48.61 14.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.122 -0.986 . . . . 0.0 109.332 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 11.0 mtt -65.45 -23.31 66.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.211 -0.93 . . . . 0.0 108.658 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 55.0 t-105 -77.9 -20.48 52.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.468 -0.77 . . . . 0.0 109.12 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.852 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.8 mt -70.84 -73.37 0.17 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 25.07 35.74 0.01 OUTLIER Glycine 0 N--CA 1.504 3.212 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.644 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.3 m 140.96 -62.61 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.852 ' O ' HD23 ' A' ' 166' ' ' LEU . 83.4 m-70 -72.76 111.45 7.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.193 -0.942 . . . . 0.0 109.611 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.49 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.2 OUTLIER -94.95 49.27 1.22 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.925 HG22 ' HA ' ' A' ' 178' ' ' THR . 25.7 p -142.91 -176.56 4.95 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.964 0.888 . . . . 0.0 110.417 -178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.958 ' HB2' HD12 ' A' ' 150' ' ' LEU . 30.6 t -69.73 135.23 88.02 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -75.03 -24.41 12.8 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.257 1.971 . . . . 0.0 113.665 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 43.8 tp -93.01 -40.57 10.47 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 117.118 -1.833 . . . . 0.0 111.412 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.72 ' SG ' HD12 ' A' ' 177' ' ' LEU . 17.2 p -107.41 -44.84 4.22 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.712 -1.243 . . . . 0.0 109.178 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 7.4 mtm180 102.28 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 122.005 0.907 . . . . 0.0 109.417 178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.72 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.3 mt -91.52 97.65 11.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.925 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.98 154.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.265 -0.897 . . . . 0.0 110.265 -179.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.896 HG13 ' CD ' ' A' ' 151' ' ' PRO . 2.3 t -100.79 -27.88 3.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.352 -0.843 . . . . 0.0 109.539 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.1 m -79.62 150.48 5.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 O-C-N 121.212 -0.93 . . . . 0.0 109.495 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.457 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.24 -175.07 4.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.907 . . . . 0.0 109.442 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.11 108.49 1.55 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.235 -0.916 . . . . 0.0 109.593 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.443 ' HA ' ' OE2' ' A' ' 133' ' ' GLU . 2.8 p30 -136.56 62.05 1.62 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.304 -0.872 . . . . 0.0 109.298 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -60.26 -72.18 0.66 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.595 HG12 HD11 ' A' ' 141' ' ' LEU . 60.0 t -119.16 112.76 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -1.122 . . . . 0.0 109.598 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.443 ' OE2' ' HA ' ' A' ' 130' ' ' ASP . 6.3 mp0 -120.41 121.02 37.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.209 -0.932 . . . . 0.0 110.411 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.95 110.23 3.27 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.611 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -67.87 -2.7 7.8 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.305 -0.872 . . . . 0.0 110.986 -177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 5.4 t -80.71 -64.68 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 120.908 -1.12 . . . . 0.0 109.438 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.451 ' C ' ' HG ' ' A' ' 138' ' ' LEU . 19.8 p -94.28 -28.54 15.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.175 -0.953 . . . . 0.0 109.252 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.451 ' HG ' ' C ' ' A' ' 137' ' ' CYS . 6.7 mt 73.5 42.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.752 . . . . 0.0 109.557 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -116.95 126.32 52.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.267 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 139' ' ' ALA . 44.7 mt-10 -45.74 121.95 3.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.313 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.875 HD23 ' NE2' ' A' ' 158' ' ' HIS . 8.5 mt -58.39 106.59 0.4 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.272 -0.893 . . . . 0.0 109.628 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.18 167.24 11.69 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -64.11 149.69 47.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.25 -0.906 . . . . 0.0 109.514 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 98.05 -1.09 59.15 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -110.46 160.79 16.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.208 -1.172 . . . . 0.0 109.599 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.1 mm-40 -121.76 80.08 1.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.424 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.37 144.76 53.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.3 -0.875 . . . . 0.0 109.639 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -109.17 122.84 48.17 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.39 -0.819 . . . . 0.0 109.669 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.588 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 17.3 m-85 -101.53 147.04 26.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.269 -0.894 . . . . 0.0 109.164 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.895 HD12 ' HB2' ' A' ' 172' ' ' CYS . 9.8 mt -100.47 159.24 30.23 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.752 -1.217 . . . . 0.0 109.684 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 36.0 Cg_endo -78.42 -42.54 0.22 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.874 2.383 . . . . 0.0 112.204 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.643 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.2 OUTLIER -53.03 -46.09 68.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.734 -1.228 . . . . 0.0 110.401 -179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.458 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.78 2.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.245 -0.582 . . . . 0.0 111.66 -176.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.02 -0.47 28.51 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 -178.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.3 m170 -51.87 120.23 5.09 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.588 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -96.91 119.93 6.52 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.562 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.643 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.5 m-85 -113.71 -171.08 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.875 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.4 m80 -88.94 158.15 18.16 Favored 'General case' 0 C--N 1.294 -1.804 0 O-C-N 120.951 -1.093 . . . . 0.0 109.852 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.43 -26.91 60.37 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -84.16 -53.18 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.816 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.585 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.27 -43.09 95.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.905 -1.122 . . . . 0.0 108.985 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 4.9 p -58.74 -33.97 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.433 -0.792 . . . . 0.0 109.233 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 10.4 m-20 -70.78 -50.85 31.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.422 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mtt -62.24 -23.29 66.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.251 -0.906 . . . . 0.0 108.831 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.704 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.6 t-105 -80.9 -24.5 38.21 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.442 -0.787 . . . . 0.0 108.973 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.556 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.99 -61.83 2.02 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.03 61.4 0.01 OUTLIER Glycine 0 N--CA 1.504 3.191 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 p 92.64 -53.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.878 -0.778 . . . . 0.0 109.156 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.542 ' N ' ' O ' ' A' ' 166' ' ' LEU . 34.7 m80 -70.85 110.98 5.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.067 . . . . 0.0 108.75 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.497 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 32.9 t -102.12 52.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 1.003 HG22 ' HA ' ' A' ' 178' ' ' THR . 3.3 p -143.61 -176.33 4.92 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.94 0.876 . . . . 0.0 109.972 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.895 ' HB2' HD12 ' A' ' 150' ' ' LEU . 11.2 t -68.95 132.48 90.44 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.704 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.1 Cg_endo -74.68 -25.75 12.27 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.169 1.913 . . . . 0.0 113.61 -177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.1 tp -93.25 -39.95 10.71 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.265 -1.774 . . . . 0.0 111.772 -177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.38 -44.29 4.56 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.61 -1.306 . . . . 0.0 108.931 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.584 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 36.5 mtm-85 101.92 35.72 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 121.967 0.889 . . . . 0.0 109.829 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 39.5 mt -95.31 99.94 11.8 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 1.003 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.89 154.73 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 0.0 110.18 -179.333 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.493 HG22 HD13 ' A' ' 150' ' ' LEU . 1.6 t -81.69 -23.3 9.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.583 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -102.15 124.47 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.169 -0.957 . . . . 0.0 109.232 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.607 -179.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.41 159.63 25.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -0.961 . . . . 0.0 109.452 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.15 138.43 57.9 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -175.01 154.48 1.83 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.68 -68.93 0.53 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.917 ' CG1' HD12 ' A' ' 141' ' ' LEU . 90.1 t -59.91 122.24 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.235 -1.156 . . . . 0.0 109.339 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 132' ' ' VAL . 1.6 mp0 -143.24 122.65 13.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.216 -0.928 . . . . 0.0 110.428 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.63 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.5 t -59.25 110.9 1.17 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -64.96 -9.37 21.01 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.092 . . . . 0.0 109.721 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 91.1 t -98.97 -66.37 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.121 -0.987 . . . . 0.0 110.732 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.4 p -93.81 -14.23 26.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.604 -1.31 . . . . 0.0 110.125 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.0 mt 59.56 39.42 21.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.203 -0.935 . . . . 0.0 109.211 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 129.88 54.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.298 -0.876 . . . . 0.0 109.418 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -45.87 132.69 8.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.48 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.917 HD12 ' CG1' ' A' ' 132' ' ' VAL . 9.2 mt -75.36 98.09 3.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.322 -0.861 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -110.33 172.71 6.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.93 . . . . 0.0 109.543 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.72 160.04 28.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.88 . . . . 0.0 109.531 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 100.16 -10.78 60.13 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 -114.96 167.03 11.16 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -1.136 . . . . 0.0 109.46 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.858 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt-10 -114.56 73.44 0.83 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.269 -0.894 . . . . 0.0 109.312 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.91 145.46 53.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -108.82 122.58 47.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.339 -0.85 . . . . 0.0 109.577 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.52 147.07 23.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.26 -0.9 . . . . 0.0 109.115 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.777 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.6 mt -103.9 159.53 29.01 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.809 -1.182 . . . . 0.0 110.054 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.787 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.39 -47.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.982 2.455 . . . . 0.0 112.125 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CB ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -53.35 -46.09 69.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.841 -1.162 . . . . 0.0 110.703 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.471 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.4 -52.86 2.14 Favored 'General case' 0 C--N 1.295 -1.777 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.814 -176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.1 0.45 28.4 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.639 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 25.0 m170 -51.75 119.18 3.95 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 179.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -94.78 113.91 4.7 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.429 -1.367 . . . . 0.0 110.835 -178.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 96.8 m-85 -108.68 -170.72 1.72 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.557 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -90.79 158.91 16.58 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.109 -0.994 . . . . 0.0 109.612 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.858 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -75.07 -27.25 59.87 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -84.06 -51.1 7.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.789 -0.569 . . . . 0.0 109.837 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 8.1 m -67.23 -42.77 83.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.921 -1.112 . . . . 0.0 109.208 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.2 p -59.77 -36.91 68.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 0.0 109.241 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -68.71 -49.45 58.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.298 -0.876 . . . . 0.0 109.681 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 23.4 mtt -63.47 -23.64 67.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.975 . . . . 0.0 108.915 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.709 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 60.3 t-105 -80.28 -22.11 41.96 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.525 -0.734 . . . . 0.0 109.162 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.592 ' O ' ' N ' ' A' ' 168' ' ' SER . 17.9 mt -64.6 -71.15 0.19 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 179.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.681 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.05 46.75 0.01 OUTLIER Glycine 0 N--CA 1.505 3.266 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.681 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 29.0 t 127.08 -63.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.477 ' O ' ' HA ' ' A' ' 166' ' ' LEU . 12.0 m-70 -72.13 110.97 6.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.307 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.58 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.1 OUTLIER -95.82 51.15 1.24 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.963 HG22 ' HA ' ' A' ' 178' ' ' THR . 16.5 p -143.88 -177.04 5.23 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.074 0.94 . . . . 0.0 110.489 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.777 ' SG ' HD12 ' A' ' 150' ' ' LEU . 9.4 t -70.0 135.12 87.42 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.709 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.2 Cg_endo -75.75 -29.87 6.68 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.091 1.861 . . . . 0.0 113.791 -178.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.452 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.5 tp -89.26 -39.68 13.34 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 117.371 -1.732 . . . . 0.0 111.752 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.4 p -106.44 -45.18 4.33 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.674 -1.266 . . . . 0.0 109.145 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.7 mtp180 101.31 37.07 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 122.007 0.908 . . . . 0.0 109.53 178.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 41.9 mt -94.66 101.41 13.26 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.963 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.99 155.13 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.201 -0.937 . . . . 0.0 110.192 -179.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.787 HG13 ' CD ' ' A' ' 151' ' ' PRO . 11.2 t -99.94 -39.5 7.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 109.308 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 4.8 m -77.68 166.26 2.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 O-C-N 121.322 -0.861 . . . . 0.0 109.413 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.453 HG12 ' OXT' ' A' ' 181' ' ' VAL . 99.3 t . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.993 -1.004 . . . . 0.0 109.519 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.1 tpp -178.65 78.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.374 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -63.89 173.16 1.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -99.5 90.62 4.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.34 -144.17 7.05 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.505 HG12 ' CD1' ' A' ' 141' ' ' LEU . 4.3 t -83.72 97.41 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.239 -1.153 . . . . 0.0 109.428 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -111.97 150.36 30.66 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 0.0 110.2 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.501 ' O ' HD23 ' A' ' 138' ' ' LEU . 15.9 t -81.2 110.5 16.74 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.01 -8.62 24.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.964 -1.085 . . . . 0.0 109.48 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 97.0 t -98.68 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.111 -0.993 . . . . 0.0 110.734 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.503 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 10.1 p -94.57 -13.66 25.78 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.71 -1.244 . . . . 0.0 110.136 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.501 HD23 ' O ' ' A' ' 134' ' ' CYS . 5.9 mt 58.61 39.69 24.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.141 -0.975 . . . . 0.0 109.21 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.503 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -101.99 125.67 48.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.323 -0.861 . . . . 0.0 109.463 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.45 115.2 0.88 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.17 -0.956 . . . . 0.0 109.375 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' CD1' HG12 ' A' ' 132' ' ' VAL . 14.7 mt -58.63 98.2 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.884 . . . . 0.0 109.543 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -115.13 162.19 17.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.465 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -55.9 147.73 18.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.244 -0.91 . . . . 0.0 109.62 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.4 5.68 27.95 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -134.39 170.85 15.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.154 -1.203 . . . . 0.0 109.705 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.78 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 41.4 mt-10 -118.19 79.87 1.44 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.19 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.63 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.57 149.58 36.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.171 -0.956 . . . . 0.0 109.796 -179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -115.75 122.61 46.0 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.371 -0.831 . . . . 0.0 109.555 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.547 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 82.8 m-85 -90.85 147.17 23.35 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.283 -0.885 . . . . 0.0 108.998 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.77 HD12 ' SG ' ' A' ' 172' ' ' CYS . 20.2 mt -99.79 159.62 29.45 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 120.911 -1.118 . . . . 0.0 110.184 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.955 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.5 Cg_endo -79.67 -46.12 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.824 2.349 . . . . 0.0 111.724 -179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.652 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -56.21 -46.14 79.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.953 -1.092 . . . . 0.0 110.663 -178.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.51 -51.23 2.18 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.674 -176.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.495 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.2 -1.67 29.76 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -178.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.628 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 22.1 m170 -49.23 120.05 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.547 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -93.29 120.2 6.16 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.967 -178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.63 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.8 m-85 -116.59 -170.87 1.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.03 158.9 17.12 Favored 'General case' 0 C--N 1.295 -1.796 0 O-C-N 120.871 -1.143 . . . . 0.0 109.818 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.78 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.73 -29.06 62.03 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -84.11 -51.65 6.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.805 -0.559 . . . . 0.0 110.001 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.584 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -64.84 -40.73 95.64 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 108.938 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.6 p -60.66 -28.59 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.427 -0.795 . . . . 0.0 109.609 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.661 ' HA ' HD12 ' A' ' 166' ' ' LEU . 0.9 OUTLIER -78.44 -49.57 13.22 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.0 109.279 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 9.2 mtp -63.61 -22.8 67.09 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.283 -0.886 . . . . 0.0 108.884 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.687 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.8 t-105 -78.95 -23.11 44.79 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.473 -0.767 . . . . 0.0 109.254 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.663 ' O ' ' N ' ' A' ' 168' ' ' SER . 32.5 mt -68.76 -72.47 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.74 41.44 0.01 OUTLIER Glycine 0 N--CA 1.508 3.465 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 166' ' ' LEU . 20.0 p 136.23 -64.81 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.636 ' O ' HD23 ' A' ' 166' ' ' LEU . 28.1 m170 -72.78 110.93 7.47 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.061 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.498 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 0.0 OUTLIER -95.23 50.59 1.27 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' THR . 51.6 p -143.51 -176.67 5.05 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.055 0.931 . . . . 0.0 110.269 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.77 ' SG ' HD12 ' A' ' 150' ' ' LEU . 35.3 t -69.92 135.0 87.62 Favored Pre-proline 0 C--N 1.3 -1.563 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.687 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.59 -22.46 15.75 Favored 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 122.33 2.02 . . . . 0.0 113.696 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.8 tp -96.13 -40.38 9.24 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 117.184 -1.807 . . . . 0.0 111.445 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.729 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.3 p -107.42 -45.2 4.13 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.652 -1.28 . . . . 0.0 109.017 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 175' ' ' CYS . 11.2 mtp180 102.68 35.29 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 CA-C-O 121.97 0.891 . . . . 0.0 109.772 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.729 HD12 ' SG ' ' A' ' 175' ' ' CYS . 34.9 mt -90.43 103.25 15.96 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.675 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.82 155.22 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.156 -0.965 . . . . 0.0 110.455 -179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.955 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.7 t -111.9 -30.18 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.465 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.68 107.23 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 109.543 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.385 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.459 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 71.76 82.77 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 -179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.55 179.97 6.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.286 -0.884 . . . . 0.0 109.476 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.91 146.76 52.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.191 -0.943 . . . . 0.0 109.485 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 116.46 160.42 12.1 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 t -61.34 143.81 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.295 -1.121 . . . . 0.0 109.552 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -115.71 123.98 49.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.203 -0.936 . . . . 0.0 110.143 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.708 ' O ' HD23 ' A' ' 138' ' ' LEU . 19.7 t -61.05 111.77 1.82 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.93 -9.23 27.79 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.034 -1.041 . . . . 0.0 109.589 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.572 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 76.2 t -98.59 -66.28 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.088 -1.008 . . . . 0.0 110.623 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 11.9 p -93.87 -15.42 25.04 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.664 -1.272 . . . . 0.0 110.092 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 134' ' ' CYS . 18.4 mt 56.96 40.97 28.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.145 -0.972 . . . . 0.0 109.223 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.421 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -105.15 127.12 52.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.409 -0.807 . . . . 0.0 109.467 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' A' ' 139' ' ' ALA . 17.0 mt-10 -45.48 117.44 1.43 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.231 -0.918 . . . . 0.0 109.46 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 14.6 mt -60.3 97.42 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -113.1 158.6 20.16 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.296 -0.878 . . . . 0.0 109.368 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -53.05 147.71 9.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.216 -0.928 . . . . 0.0 109.615 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 117.01 -5.22 18.28 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -130.01 179.17 6.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -1.184 . . . . 0.0 109.524 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.678 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.6 mp0 -129.8 79.52 1.91 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.257 -0.902 . . . . 0.0 109.479 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.13 142.68 54.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -108.65 122.48 47.2 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.262 -0.899 . . . . 0.0 109.704 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.415 ' CD2' ' HA3' ' A' ' 156' ' ' GLY . 5.8 m-85 -94.82 147.24 23.56 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.581 HD12 ' SG ' ' A' ' 172' ' ' CYS . 15.7 mt -97.29 151.98 37.99 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 120.743 -1.223 . . . . 0.0 110.017 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 150' ' ' LEU . 36.8 Cg_endo -79.29 -0.77 11.01 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.154 2.569 . . . . 0.0 111.69 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.615 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mtp-105 -92.96 -46.74 7.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.903 -1.123 . . . . 0.0 110.256 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.468 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.2 -48.7 2.31 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.527 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 112.85 5.26 23.94 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 -179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 24.9 m170 -62.5 119.47 9.22 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.415 ' HA3' ' CD2' ' A' ' 149' ' ' PHE . . . -95.21 120.43 6.48 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.488 -1.339 . . . . 0.0 110.842 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -116.4 -174.76 2.62 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.562 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.3 m80 -85.86 159.76 19.61 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.94 -1.1 . . . . 0.0 110.086 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.678 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.89 -28.91 61.79 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -84.65 -51.28 6.95 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.893 -0.504 . . . . 0.0 110.021 179.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.572 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 9.7 m -66.3 -37.59 85.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.758 -1.213 . . . . 0.0 109.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -65.48 -32.21 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.393 -0.817 . . . . 0.0 109.604 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.726 ' HA ' HD12 ' A' ' 166' ' ' LEU . 17.5 m-20 -74.86 -50.49 16.85 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.123 -0.986 . . . . 0.0 109.5 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.7 mmm -65.54 -23.41 66.86 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.303 -0.873 . . . . 0.0 108.65 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.733 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 38.6 t-105 -76.76 -20.93 55.93 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 16.4 mt -77.11 -74.09 0.26 Allowed 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.33 35.57 0.01 OUTLIER Glycine 0 N--CA 1.503 3.15 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 166' ' ' LEU . 8.0 t 144.67 -61.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 71.8 m80 -72.26 111.38 7.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.291 -0.88 . . . . 0.0 109.526 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.58 44.71 1.11 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' THR . 42.8 p -137.41 -178.27 5.15 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.112 0.958 . . . . 0.0 110.243 -178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.581 ' SG ' HD12 ' A' ' 150' ' ' LEU . 44.2 t -71.33 136.26 84.13 Favored Pre-proline 0 C--N 1.299 -1.608 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.733 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.6 Cg_endo -74.01 -19.32 20.58 Favored 'Trans proline' 0 C--N 1.316 -1.164 0 C-N-CA 122.173 1.915 . . . . 0.0 113.68 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 13.2 tp -100.42 -40.24 7.57 Favored 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 117.001 -1.88 . . . . 0.0 111.262 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.676 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.7 p -106.68 -44.81 4.37 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.577 -1.327 . . . . 0.0 108.417 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.593 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 52.7 mtp180 99.25 31.9 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 CA-C-O 121.027 0.441 . . . . 0.0 111.518 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.676 HD12 ' SG ' ' A' ' 175' ' ' CYS . 8.9 mt -79.75 94.79 5.82 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.308 -1.368 . . . . 0.0 107.308 177.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.81 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -46.33 144.28 2.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.692 -1.255 . . . . 0.0 109.484 -179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -109.26 -16.37 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.321 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.53 116.57 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.283 -0.885 . . . . 0.0 109.294 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.529 -179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -129.04 142.26 50.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 109.475 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.41 109.96 2.11 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.265 -0.897 . . . . 0.0 109.399 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -100.4 156.25 17.36 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -96.96 -132.04 7.22 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.1 t -110.4 119.82 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.241 -1.152 . . . . 0.0 109.335 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -104.18 121.61 43.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.243 -0.911 . . . . 0.0 110.385 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.586 ' O ' HD23 ' A' ' 138' ' ' LEU . 18.3 t -56.24 110.58 0.78 Allowed 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.46 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.87 -8.15 20.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.066 -1.021 . . . . 0.0 109.74 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.568 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 92.6 t -98.57 -66.13 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.117 -0.989 . . . . 0.0 110.704 -179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.5 p -92.92 -17.64 23.75 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.565 -1.334 . . . . 0.0 110.169 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.2 mt 60.28 39.89 18.44 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.155 -0.966 . . . . 0.0 109.405 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.428 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -112.14 129.96 56.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.408 ' C ' ' O ' ' A' ' 139' ' ' ALA . 3.6 pt-20 -45.52 119.96 2.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.353 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.487 HD23 ' NE2' ' A' ' 158' ' ' HIS . 11.3 mt -58.32 95.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.191 -0.943 . . . . 0.0 109.335 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -86.63 174.29 8.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.305 -0.872 . . . . 0.0 109.455 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -79.76 167.25 20.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.45 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 86.44 2.32 85.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.429 ' C ' ' HG3' ' A' ' 146' ' ' GLU . 2.4 mm-40 -111.7 -177.17 3.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.269 -1.136 . . . . 0.0 109.393 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.867 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -133.31 77.6 1.74 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 0.0 109.324 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -68.85 171.22 8.25 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.176 -0.953 . . . . 0.0 109.616 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -138.26 122.39 18.0 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 149' ' ' PHE . 7.5 m-85 -100.93 146.85 26.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.18 -0.95 . . . . 0.0 109.269 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.893 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.0 mt -99.62 159.44 29.98 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 120.9 -1.125 . . . . 0.0 109.594 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.748 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.3 Cg_endo -77.82 -43.45 0.21 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.648 2.232 . . . . 0.0 111.724 -178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.697 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.8 OUTLIER -53.85 -46.17 71.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.853 -1.155 . . . . 0.0 110.235 -179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.88 -50.63 2.16 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 120.011 -0.675 . . . . 0.0 111.861 -176.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -3.42 29.96 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 23.1 m170 -48.64 120.29 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.295 . . . . 0.0 107.919 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -95.09 126.51 8.77 Favored Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.15 -179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.627 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 82.5 m-85 -120.38 -169.55 1.82 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.549 ' O ' HG12 ' A' ' 162' ' ' VAL . 5.5 m80 -90.94 155.97 18.33 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.699 -1.25 . . . . 0.0 109.351 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -72.7 -27.07 61.85 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -83.85 -53.12 5.82 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 116.136 -0.484 . . . . 0.0 109.94 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.568 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 14.1 m -64.26 -40.77 96.67 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.819 -1.175 . . . . 0.0 108.8 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.549 HG12 ' O ' ' A' ' 158' ' ' HIS . 5.2 p -60.92 -29.95 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.579 -0.7 . . . . 0.0 109.475 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 8.9 m-20 -76.25 -49.94 15.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.0 109.358 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.1 mmm -63.09 -23.45 67.45 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.195 -0.941 . . . . 0.0 108.6 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.703 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 63.7 t-105 -80.57 -23.85 39.62 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.555 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -52.29 -61.49 2.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.598 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.16 61.59 0.01 OUTLIER Glycine 0 N--CA 1.505 3.297 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.598 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 3.9 p 91.27 -52.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.778 -0.836 . . . . 0.0 109.091 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.55 ' N ' ' O ' ' A' ' 166' ' ' LEU . 42.6 m80 -70.71 110.66 5.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.064 -1.023 . . . . 0.0 108.638 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.417 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.4 OUTLIER -101.85 43.74 1.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.931 HG22 ' HA ' ' A' ' 178' ' ' THR . 50.4 p -132.29 -177.23 4.37 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.94 0.876 . . . . 0.0 109.896 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.893 ' HB2' HD12 ' A' ' 150' ' ' LEU . 22.9 t -69.91 133.62 88.1 Favored Pre-proline 0 C--N 1.297 -1.716 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.703 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.7 Cg_endo -74.95 -21.61 15.79 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 122.132 1.888 . . . . 0.0 113.425 -177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 135' ' ' ALA . 6.8 tp -96.4 -40.18 9.23 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 117.113 -1.835 . . . . 0.0 111.395 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.693 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.2 p -106.49 -45.83 4.16 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.7 -1.25 . . . . 0.0 108.956 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.59 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 85.7 mtm180 101.76 42.12 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 122.155 0.979 . . . . 0.0 109.44 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.697 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 43.9 mt -94.86 91.3 6.37 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.931 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.48 153.79 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.32 -0.862 . . . . 0.0 110.597 -178.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.748 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.2 t -116.72 -7.7 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.37 -0.831 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.76 125.43 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.389 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.703 ' OXT' HG22 ' A' ' 181' ' ' VAL . 5.8 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.995 -1.003 . . . . 0.0 109.486 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.578 ' HB3' ' OD2' ' A' ' 130' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 56.56 -173.22 0.07 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 0.0 109.328 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -54.66 117.74 3.62 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.578 ' OD2' ' HB3' ' A' ' 127' ' ' ALA . 21.4 p30 -172.89 165.22 5.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.209 -0.932 . . . . 0.0 109.427 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -122.37 -121.73 2.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.0 t -80.15 118.69 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.277 -1.131 . . . . 0.0 109.391 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.409 ' OE2' ' HB2' ' A' ' 130' ' ' ASP . 2.4 mp0 -105.76 133.13 50.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.165 -0.96 . . . . 0.0 110.147 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 13.5 t -69.03 112.18 5.5 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.6 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.89 -8.65 30.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 109.344 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 89.4 t -98.73 -66.18 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 110.63 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.2 p -93.41 -13.84 27.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.597 -1.315 . . . . 0.0 110.179 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 9.3 mt 55.54 39.63 31.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.149 -0.969 . . . . 0.0 109.371 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.488 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -110.01 130.96 55.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.348 -0.845 . . . . 0.0 109.474 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 142' ' ' GLU . 1.1 mt-10 -45.41 119.5 2.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.0 109.417 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.621 HD23 ' NE2' ' A' ' 158' ' ' HIS . 16.5 mt -58.53 95.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 140' ' ' GLU . 3.3 mm-40 -88.02 160.89 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.945 . . . . 0.0 109.435 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -74.32 140.88 45.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.196 -0.94 . . . . 0.0 109.552 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 126.32 -15.24 6.83 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -110.09 -177.24 3.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -1.158 . . . . 0.0 109.381 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.951 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.0 OUTLIER -122.32 82.48 1.97 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.304 -0.873 . . . . 0.0 109.484 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.26 143.58 53.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.075 -1.016 . . . . 0.0 109.556 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -109.18 122.66 47.78 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.266 -0.896 . . . . 0.0 109.756 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 10.9 m-85 -100.1 146.92 26.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.241 -0.912 . . . . 0.0 108.828 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.909 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -100.77 159.18 30.29 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 120.835 -1.166 . . . . 0.0 109.866 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.684 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.9 Cg_endo -78.15 -44.06 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.762 2.308 . . . . 0.0 111.992 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.84 HH21 HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -52.53 -45.54 66.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.832 -1.168 . . . . 0.0 110.273 -179.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.515 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.68 -51.13 2.17 Favored 'General case' 0 C--N 1.299 -1.611 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.775 -176.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.01 -2.43 28.55 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.62 ' HB3' ' CE1' ' A' ' 157' ' ' PHE . 23.4 m170 -50.08 120.72 4.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.242 . . . . 0.0 107.719 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.78 120.37 6.54 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.325 -1.417 . . . . 0.0 110.516 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.645 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 80.1 m-85 -114.66 -170.8 1.81 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.621 ' NE2' HD23 ' A' ' 141' ' ' LEU . 5.5 m80 -89.03 159.5 17.55 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.08 -1.013 . . . . 0.0 109.917 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.951 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.69 -28.84 60.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -84.03 -51.49 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.824 -0.548 . . . . 0.0 110.054 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.1 m -65.5 -38.56 90.07 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.803 -1.186 . . . . 0.0 108.97 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 6.5 p -63.2 -36.55 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.596 -0.841 . . . . 0.0 109.618 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.645 ' HA ' HD12 ' A' ' 166' ' ' LEU . 2.2 m-20 -70.8 -51.97 23.52 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.164 -0.96 . . . . 0.0 109.678 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 45.4 mtt -64.32 -23.12 67.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.204 -0.935 . . . . 0.0 108.939 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.714 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.1 t-105 -78.41 -20.81 50.34 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.451 -0.78 . . . . 0.0 109.194 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.738 HD23 ' O ' ' A' ' 169' ' ' HIS . 27.4 mt -73.55 -72.84 0.24 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.657 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.94 41.97 0.01 OUTLIER Glycine 0 N--CA 1.508 3.459 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.657 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 8.2 t 137.72 -64.45 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.738 ' O ' HD23 ' A' ' 166' ' ' LEU . 44.1 m170 -72.27 111.43 7.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.356 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.43 50.49 1.15 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 178' ' ' THR . 65.0 p -143.03 -177.66 5.45 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.972 0.892 . . . . 0.0 110.231 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.909 ' HB2' HD12 ' A' ' 150' ' ' LEU . 35.0 t -70.46 134.91 86.49 Favored Pre-proline 0 C--N 1.299 -1.619 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.714 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.48 -22.73 15.73 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 C-N-CA 122.297 1.998 . . . . 0.0 113.572 -178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.6 HD13 ' HB2' ' A' ' 135' ' ' ALA . 14.4 tp -96.33 -40.2 9.25 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 117.159 -1.816 . . . . 0.0 111.48 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.7 ' SG ' HD12 ' A' ' 177' ' ' LEU . 16.4 p -106.64 -45.66 4.17 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.668 -1.27 . . . . 0.0 108.826 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.587 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 11.5 mtm180 102.07 38.03 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.971 0.891 . . . . 0.0 109.66 178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.704 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 40.4 mt -89.79 91.77 8.77 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.898 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.6 154.96 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.214 -0.929 . . . . 0.0 110.517 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.684 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.5 t -116.78 -6.03 11.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -114.43 146.58 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.198 -0.939 . . . . 0.0 109.33 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.45 -179.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 128' ' ' MET . 2.0 ptp -136.42 98.79 3.92 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.422 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -96.37 143.92 26.98 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.289 -0.882 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.73 105.84 7.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.257 -0.902 . . . . 0.0 109.542 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.88 -129.64 6.88 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.429 . . . . 0.0 109.526 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 133' ' ' GLU . 43.1 t -119.75 158.43 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.232 -1.158 . . . . 0.0 109.454 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.44 ' N ' HG12 ' A' ' 132' ' ' VAL . 0.5 OUTLIER -116.92 136.12 53.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 110.291 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 26.5 t -77.73 111.07 13.14 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.16 -8.65 18.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.786 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.0 t -98.73 -66.33 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.1 -1.0 . . . . 0.0 110.68 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.1 p -93.73 -16.46 24.2 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.61 -1.306 . . . . 0.0 110.287 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.5 mt 59.35 40.3 21.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.1 -1.0 . . . . 0.0 109.395 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.37 128.02 54.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.355 -0.84 . . . . 0.0 109.617 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 142' ' ' GLU . 7.0 mt-10 -45.67 116.01 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.242 -0.911 . . . . 0.0 109.243 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.4 HD23 ' NE2' ' A' ' 158' ' ' HIS . 10.9 mt -58.18 125.58 23.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.202 -0.936 . . . . 0.0 109.423 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.419 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 1.2 mt-10 -117.22 157.95 25.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.524 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -65.15 137.75 57.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.39 -0.819 . . . . 0.0 109.431 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 118.07 -26.78 7.71 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.561 ' OE1' ' CD2' ' A' ' 158' ' ' HIS . 3.0 mt-10 -83.7 -170.56 3.13 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.268 -1.136 . . . . 0.0 109.447 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.767 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 36.9 mm-40 -133.83 80.42 1.87 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.331 -0.856 . . . . 0.0 109.6 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.94 176.95 2.83 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.32 -0.863 . . . . 0.0 109.209 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 4.9 mtp180 -148.9 122.39 9.11 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.519 ' CD1' ' HA3' ' A' ' 156' ' ' GLY . 12.9 m-85 -104.05 146.53 28.59 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 0.0 109.73 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.913 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.4 mt -99.65 161.9 22.95 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.144 -0.973 . . . . 0.0 109.268 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.766 ' CD ' HG13 ' A' ' 179' ' ' VAL . 35.1 Cg_endo -77.31 -38.61 0.72 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.659 2.239 . . . . 0.0 111.947 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.689 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.3 OUTLIER -58.73 -46.23 87.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.77 -1.206 . . . . 0.0 110.268 -179.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.51 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.5 p -120.91 -50.23 2.17 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.683 -0.636 . . . . 0.0 111.695 -176.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 110.13 -6.25 30.57 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 -178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 27.3 m170 -46.77 134.64 9.71 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.057 -1.26 . . . . 0.0 107.675 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 149' ' ' PHE . . . -109.68 131.91 10.75 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.575 -179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.63 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 23.2 m-85 -129.52 153.64 47.8 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.561 ' CD2' ' OE1' ' A' ' 145' ' ' GLU . 11.3 m80 -49.17 154.68 0.77 Allowed 'General case' 0 C--N 1.287 -2.132 0 O-C-N 121.203 -0.936 . . . . 0.0 110.104 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.767 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.62 -25.73 59.43 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -83.77 -54.53 4.84 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.881 -0.512 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.589 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.5 m -61.53 -42.04 98.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.813 -1.18 . . . . 0.0 108.472 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.8 p -58.83 -24.66 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 119.784 -0.766 . . . . 0.0 109.594 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 21.3 m-20 -81.86 -48.55 11.41 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.176 -0.953 . . . . 0.0 109.034 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.0 mmt -63.03 -22.96 67.22 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.29 -0.881 . . . . 0.0 108.685 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.702 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 65.3 t-105 -80.62 -23.83 39.5 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.513 -0.742 . . . . 0.0 109.13 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.56 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.9 mt -51.59 -60.35 3.25 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.596 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.0 61.48 0.01 OUTLIER Glycine 0 N--CA 1.505 3.235 0 N-CA-C 111.635 -0.586 . . . . 0.0 111.635 177.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.596 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 1.5 m 90.96 -53.03 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.709 -0.877 . . . . 0.0 109.241 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 166' ' ' LEU . 51.4 m170 -71.5 110.91 6.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.02 -1.05 . . . . 0.0 108.85 179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.536 ' HA ' ' CD2' ' A' ' 166' ' ' LEU . 87.9 p -101.34 48.36 0.89 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.802 HG22 ' HA ' ' A' ' 178' ' ' THR . 51.1 p -136.24 -177.02 4.52 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.0 0.905 . . . . 0.0 110.032 -178.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.913 ' HB2' HD12 ' A' ' 150' ' ' LEU . 20.4 t -69.93 132.88 88.35 Favored Pre-proline 0 C--N 1.297 -1.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.702 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.0 Cg_endo -74.73 -20.99 16.98 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.296 1.997 . . . . 0.0 113.495 -177.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.5 tp -97.35 -40.16 8.86 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 117.095 -1.842 . . . . 0.0 111.371 -177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.699 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.8 p -106.39 -45.96 4.15 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.71 -1.244 . . . . 0.0 108.888 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.588 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 77.2 mtm180 101.49 41.14 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-O 122.137 0.97 . . . . 0.0 109.392 178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.699 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.1 mt -94.29 88.52 5.59 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.802 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.65 150.52 0.1 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.319 -0.863 . . . . 0.0 110.543 -178.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.766 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.4 t -101.98 -33.32 3.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.534 -0.729 . . . . 0.0 109.091 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.1 m -83.99 167.14 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 O-C-N 121.331 -0.855 . . . . 0.0 109.406 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.643 ' O ' HG13 ' A' ' 181' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.534 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.77 52.77 2.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.495 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.23 97.77 7.09 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.207 -0.933 . . . . 0.0 109.497 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -104.43 65.33 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.321 -0.862 . . . . 0.0 109.414 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 104.83 166.52 24.25 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.654 HG11 ' H ' ' A' ' 156' ' ' GLY . 3.2 t -91.26 123.03 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.189 -1.183 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.22 122.34 33.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.28 -0.887 . . . . 0.0 110.41 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.6 t -53.65 111.8 0.79 Allowed 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.771 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -68.22 -6.95 26.37 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.033 -1.042 . . . . 0.0 109.403 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.566 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 78.5 t -98.76 -66.11 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.245 -0.909 . . . . 0.0 110.695 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.569 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 12.4 p -94.57 -11.44 29.45 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.656 -1.278 . . . . 0.0 110.313 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 16.0 mt 56.07 38.2 29.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.064 -1.023 . . . . 0.0 109.288 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.569 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -109.83 123.24 49.22 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.377 -0.827 . . . . 0.0 109.338 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 139' ' ' ALA . 2.8 mt-10 -45.59 121.36 3.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.239 -0.913 . . . . 0.0 109.278 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.771 HD22 ' HB2' ' A' ' 147' ' ' ALA . 10.0 mt -58.16 95.63 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.242 -0.911 . . . . 0.0 109.402 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -92.49 173.41 7.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -0.891 . . . . 0.0 109.522 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -74.11 146.78 43.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.292 -0.88 . . . . 0.0 109.505 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.3 29.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -111.7 178.21 4.4 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.257 -1.143 . . . . 0.0 109.533 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.824 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 37.1 mt-10 -127.89 84.26 2.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.525 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.771 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -69.46 176.18 3.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.504 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HD3' HG11 ' A' ' 162' ' ' VAL . 53.1 mtp180 -143.9 122.04 12.19 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.3 -0.875 . . . . 0.0 108.641 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -98.4 147.05 25.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.259 -0.9 . . . . 0.0 109.1 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.739 HD12 ' SG ' ' A' ' 172' ' ' CYS . 17.3 mt -103.83 160.72 25.2 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 120.955 -1.091 . . . . 0.0 109.891 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.614 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.2 Cg_endo -78.34 -46.6 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.755 2.303 . . . . 0.0 111.961 -178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.709 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -52.93 -46.42 68.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.93 -1.106 . . . . 0.0 110.465 -178.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.0 p -120.99 -51.34 2.12 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.581 -0.699 . . . . 0.0 111.992 -176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 108.98 -1.06 31.6 Favored Glycine 0 N--CA 1.483 1.819 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 22.7 m170 -49.95 120.25 4.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.063 -1.257 . . . . 0.0 107.617 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.654 ' H ' HG11 ' A' ' 132' ' ' VAL . . . -93.76 127.93 9.25 Favored Glycine 0 N--CA 1.488 2.129 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.249 -179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 83.9 m-85 -123.58 -168.99 1.86 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.599 ' NE2' HD23 ' A' ' 141' ' ' LEU . 4.7 m80 -93.12 159.12 15.43 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 120.784 -1.198 . . . . 0.0 109.313 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.824 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.38 -28.53 61.15 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 178.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.42 -46.84 11.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.917 -0.489 . . . . 0.0 110.327 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.566 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 10.1 m -71.26 -39.43 71.61 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.603 -1.311 . . . . 0.0 108.938 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.575 HG12 ' O ' ' A' ' 158' ' ' HIS . 2.7 p -65.9 -40.25 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 119.912 -0.715 . . . . 0.0 109.662 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.769 ' HA ' HD12 ' A' ' 166' ' ' LEU . 29.7 m-20 -68.33 -49.69 58.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.31 -0.868 . . . . 0.0 109.684 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.28 -23.75 66.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.731 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 41.3 t-105 -76.15 -20.32 57.68 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.949 HD23 ' O ' ' A' ' 169' ' ' HIS . 20.8 mt -75.96 -73.98 0.24 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.637 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.59 35.13 0.01 OUTLIER Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 166' ' ' LEU . 1.9 t 143.71 -60.48 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.949 ' O ' HD23 ' A' ' 166' ' ' LEU . 60.2 m170 -71.94 111.29 7.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.918 . . . . 0.0 109.14 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.61 48.35 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.908 HG22 ' HA ' ' A' ' 178' ' ' THR . 67.6 p -143.25 -177.71 5.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.159 0.981 . . . . 0.0 110.419 -178.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' A' ' 150' ' ' LEU . 34.6 t -70.89 135.95 85.32 Favored Pre-proline 0 N--CA 1.492 1.629 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.731 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -74.55 -24.13 14.15 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.154 1.902 . . . . 0.0 113.518 -178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 135' ' ' ALA . 27.4 tp -94.15 -40.44 10.04 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 117.217 -1.793 . . . . 0.0 111.521 -177.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.585 ' O ' ' CB ' ' A' ' 176' ' ' ARG . 17.0 p -107.21 -44.89 4.24 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.627 -1.296 . . . . 0.0 108.989 179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 48.4 mtp180 101.82 37.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 122.163 0.982 . . . . 0.0 109.503 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.709 ' HB3' ' CD ' ' A' ' 152' ' ' ARG . 32.8 mt -87.49 91.46 8.74 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.908 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.17 154.8 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.181 -0.949 . . . . 0.0 110.293 -179.244 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.614 HG13 ' CD ' ' A' ' 151' ' ' PRO . 1.1 t -121.84 -12.5 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.371 -0.83 . . . . 0.0 109.368 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 32.6 m -78.3 166.96 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 121.26 -0.9 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.406 ' O ' HG12 ' A' ' 181' ' ' VAL . 60.8 t . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 118.071 -0.966 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.299 0.571 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -140.51 -179.84 6.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.0 109.407 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.32 84.37 5.17 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.229 -0.919 . . . . 0.0 109.478 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -66.8 140.16 57.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.569 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -162.23 -79.65 0.03 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.94 133.02 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -1.159 . . . . 0.0 109.349 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -125.66 122.63 36.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 110.19 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.497 ' O ' HD23 ' A' ' 138' ' ' LEU . 21.0 t -50.85 109.67 0.34 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.657 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -65.73 -8.44 21.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.079 -1.013 . . . . 0.0 109.761 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 88.4 t -98.59 -66.31 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.015 -1.053 . . . . 0.0 110.542 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.467 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 8.6 p -95.46 -15.42 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.688 -1.257 . . . . 0.0 110.032 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.497 HD23 ' O ' ' A' ' 134' ' ' CYS . 7.8 mt 61.56 40.2 13.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -104.41 132.53 50.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.847 . . . . 0.0 109.426 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -45.6 134.82 6.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.841 . . . . 0.0 109.445 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 147' ' ' ALA . 34.5 mt -82.48 97.61 8.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -0.914 . . . . 0.0 109.386 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -129.79 165.15 22.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.925 . . . . 0.0 109.532 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -48.07 148.87 1.58 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 120.74 -19.47 8.97 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -131.1 -173.12 3.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -1.175 . . . . 0.0 109.605 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.727 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 2.0 mm-40 -128.65 87.32 2.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.24 -0.912 . . . . 0.0 109.488 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.491 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -68.15 177.5 2.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 0.0 109.381 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 12.3 mtp180 -149.11 122.86 9.26 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.381 -0.825 . . . . 0.0 108.982 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.574 ' C ' HD23 ' A' ' 150' ' ' LEU . 16.4 m-85 -101.37 146.69 27.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.391 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.834 HD12 ' HB2' ' A' ' 172' ' ' CYS . 5.5 mt -99.87 160.33 27.54 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.125 -0.984 . . . . 0.0 109.756 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.7 Cg_endo -77.92 -35.89 1.27 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.815 2.344 . . . . 0.0 111.611 -179.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.635 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.1 OUTLIER -63.61 -46.4 85.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.849 -1.157 . . . . 0.0 110.216 -179.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 2.1 p -120.47 -51.26 2.19 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.647 -176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.9 -7.44 27.52 Favored Glycine 0 N--CA 1.484 1.86 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 26.3 m170 -44.93 133.54 6.24 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.181 -1.188 . . . . 0.0 107.81 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -109.94 122.79 6.49 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.239 -1.458 . . . . 0.0 110.831 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.624 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 41.7 m-85 -122.83 154.63 37.99 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.552 ' O ' HG12 ' A' ' 162' ' ' VAL . 10.3 m80 -51.46 155.68 1.45 Allowed 'General case' 0 C--N 1.286 -2.167 0 O-C-N 121.297 -0.877 . . . . 0.0 110.13 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.99 -26.02 59.26 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -83.89 -53.43 5.59 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.875 -0.516 . . . . 0.0 109.728 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.575 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.0 m -64.07 -42.52 96.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.876 -1.14 . . . . 0.0 108.875 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.7 p -60.56 -30.25 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.764 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.4 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 7.2 m-20 -76.12 -47.04 25.93 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.122 -0.986 . . . . 0.0 109.501 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 40.1 mtt -65.99 -23.65 66.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.186 -0.946 . . . . 0.0 108.777 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.711 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 54.9 t-105 -76.4 -20.29 57.27 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.864 HD23 ' O ' ' A' ' 169' ' ' HIS . 23.1 mt -68.51 -72.22 0.19 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.671 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 19.9 43.07 0.01 OUTLIER Glycine 0 N--CA 1.504 3.209 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.671 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 11.6 t 134.12 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.864 ' O ' HD23 ' A' ' 166' ' ' LEU . 35.8 m80 -72.36 111.61 7.7 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.936 . . . . 0.0 109.5 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.582 ' HA ' HD22 ' A' ' 166' ' ' LEU . 94.8 p -94.87 48.91 1.21 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.812 HG22 ' HA ' ' A' ' 178' ' ' THR . 24.0 p -143.75 -176.7 5.08 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.078 0.942 . . . . 0.0 110.539 -178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.834 ' HB2' HD12 ' A' ' 150' ' ' LEU . 15.2 t -69.85 135.25 87.75 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.711 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.9 Cg_endo -74.45 -28.97 9.73 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.159 1.906 . . . . 0.0 113.801 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.8 tp -89.28 -40.35 12.87 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 117.449 -1.7 . . . . 0.0 111.602 -177.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.738 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.2 p -107.29 -44.77 4.26 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.667 -1.27 . . . . 0.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.582 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 94.0 mtt180 102.12 35.46 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 CA-C-O 121.979 0.895 . . . . 0.0 109.624 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.738 HD12 ' SG ' ' A' ' 175' ' ' CYS . 40.7 mt -93.29 106.05 18.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.812 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.04 155.16 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.214 -0.929 . . . . 0.0 110.186 -179.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.626 HG22 HD13 ' A' ' 150' ' ' LEU . 1.1 t -92.98 -44.26 13.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.296 -0.877 . . . . 0.0 109.351 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 180' ' ' VAL . 12.0 m -76.98 152.44 5.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.574 ' OXT' HG13 ' A' ' 181' ' ' VAL . 11.3 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.415 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.6 mtt 52.28 -174.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -0.888 . . . . 0.0 109.458 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -86.27 176.54 7.87 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.206 -0.934 . . . . 0.0 109.592 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -73.45 176.73 5.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.331 -0.855 . . . . 0.0 109.488 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -79.64 -108.16 0.25 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 32.1 t -83.89 148.28 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.167 -1.196 . . . . 0.0 109.441 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.91 147.91 52.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.229 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.583 ' O ' HD23 ' A' ' 138' ' ' LEU . 22.2 t -83.6 112.03 19.64 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.544 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.45 -8.18 24.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.99 . . . . 0.0 109.678 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 93.3 t -98.66 -66.37 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 110.513 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.419 ' SG ' ' HB3' ' A' ' 139' ' ' ALA . 13.0 p -93.48 -16.55 24.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.658 -1.277 . . . . 0.0 109.991 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 134' ' ' CYS . 6.9 mt 59.68 40.81 19.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.186 -0.946 . . . . 0.0 109.302 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.419 ' HB3' ' SG ' ' A' ' 137' ' ' CYS . . . -107.78 133.02 52.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.331 -0.856 . . . . 0.0 109.384 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -45.38 134.41 6.74 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.267 -0.895 . . . . 0.0 109.437 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 8.7 mt -79.14 112.34 16.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.561 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -134.54 163.47 29.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -54.76 157.44 3.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.33 -22.03 16.22 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -122.82 175.27 6.64 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.212 -1.169 . . . . 0.0 109.566 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.869 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 1.1 mm-40 -117.79 81.09 1.61 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.529 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.653 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -69.0 141.49 54.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 109.541 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.2 mtp180 -108.94 122.52 47.39 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.499 -0.751 . . . . 0.0 109.539 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 31.0 m-85 -100.09 147.0 26.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.242 -0.911 . . . . 0.0 108.754 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.861 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.2 mt -101.77 154.15 37.49 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.846 -1.159 . . . . 0.0 110.0 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.662 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.3 Cg_endo -78.43 -41.33 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.908 2.405 . . . . 0.0 111.827 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.647 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -52.53 -45.9 66.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.9 -1.125 . . . . 0.0 110.154 -179.266 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.479 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.73 -52.09 2.13 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.262 -0.575 . . . . 0.0 111.666 -176.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.99 1.48 25.37 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.931 -1.667 . . . . 0.0 108.931 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.605 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.2 m170 -56.17 120.92 8.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.096 -1.238 . . . . 0.0 107.695 179.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 128.39 9.49 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.491 -178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.653 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 79.0 m-85 -124.65 -170.86 2.23 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.7 m80 -93.36 159.17 15.38 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.992 -1.067 . . . . 0.0 109.826 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.869 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.5 -27.84 60.73 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -83.98 -52.25 6.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.899 -0.501 . . . . 0.0 109.796 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.564 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 10.7 m -65.11 -43.16 92.93 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.9 -1.125 . . . . 0.0 109.075 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.6 p -58.79 -29.2 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.376 -0.828 . . . . 0.0 109.431 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 1.2 m-20 -77.38 -46.94 21.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.183 -0.948 . . . . 0.0 109.376 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 58.4 mtp -63.21 -23.62 67.51 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.143 -0.973 . . . . 0.0 108.464 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.71 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 58.9 t-105 -83.3 -21.63 33.18 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.551 -0.718 . . . . 0.0 109.087 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.557 ' O ' ' C ' ' A' ' 167' ' ' GLY . 11.9 mt -49.86 -56.59 9.86 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.6 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.52 61.18 0.01 OUTLIER Glycine 0 N--CA 1.505 3.287 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 177.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.0 m 88.88 -52.02 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.777 -0.837 . . . . 0.0 109.288 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.543 ' N ' ' O ' ' A' ' 166' ' ' LEU . 31.8 m80 -71.92 110.87 6.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.997 -1.065 . . . . 0.0 108.969 179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.53 ' HA ' HD22 ' A' ' 166' ' ' LEU . 17.1 m -99.56 53.58 0.94 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.894 HG22 ' CA ' ' A' ' 178' ' ' THR . 12.0 p -143.58 -175.92 4.76 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 121.966 0.888 . . . . 0.0 110.094 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.861 ' HB2' HD12 ' A' ' 150' ' ' LEU . 10.0 t -68.85 132.36 90.66 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.71 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.3 Cg_endo -73.82 -28.77 11.12 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.134 1.889 . . . . 0.0 113.85 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.544 HD13 ' HB2' ' A' ' 135' ' ' ALA . 5.2 tp -89.42 -39.82 13.13 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 117.285 -1.766 . . . . 0.0 111.612 -177.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.719 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.86 -45.17 4.25 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.654 -1.279 . . . . 0.0 109.295 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.585 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 49.5 mtt85 102.0 36.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.976 0.894 . . . . 0.0 109.902 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.719 HD12 ' SG ' ' A' ' 175' ' ' CYS . 36.4 mt -96.77 98.22 9.96 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 177.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.894 ' CA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.05 154.95 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.226 -0.922 . . . . 0.0 110.271 -179.173 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.741 HG22 HD13 ' A' ' 150' ' ' LEU . 1.7 t -90.47 -46.49 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.255 -0.903 . . . . 0.0 109.268 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.01 153.45 6.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.34 -0.85 . . . . 0.0 109.536 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.456 179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.257 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.8 tmm? -160.35 64.73 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.359 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -81.81 76.61 8.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.867 . . . . 0.0 109.689 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -75.47 97.73 3.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.335 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.47 -175.27 0.1 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.5 t -90.51 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.348 -1.089 . . . . 0.0 109.423 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.62 122.67 47.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.416 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.971 ' O ' HD23 ' A' ' 138' ' ' LEU . 33.1 t -63.44 111.38 2.29 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.05 -8.76 17.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.126 -0.984 . . . . 0.0 109.82 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.56 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 85.5 t -98.69 -66.34 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.007 -1.058 . . . . 0.0 110.625 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.429 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 12.4 p -93.91 -17.27 23.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.691 -1.256 . . . . 0.0 110.279 -179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 134' ' ' CYS . 8.2 mt 59.91 41.58 17.58 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.021 -1.05 . . . . 0.0 109.102 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.429 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -105.83 125.97 51.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.408 -0.807 . . . . 0.0 109.7 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -45.52 123.29 4.11 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.332 -0.855 . . . . 0.0 109.431 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 18.0 mt -68.67 109.91 4.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.235 -0.916 . . . . 0.0 109.598 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -133.72 171.57 13.95 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -56.44 141.59 41.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.96 -28.04 6.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -117.97 -179.29 3.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.16 . . . . 0.0 109.407 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.493 ' O ' ' HA ' ' A' ' 158' ' ' HIS . 14.8 mm-40 -128.97 155.95 44.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.163 -0.961 . . . . 0.0 109.299 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -129.44 177.18 7.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.521 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.6 OUTLIER -148.15 122.59 9.72 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.335 -0.853 . . . . 0.0 108.813 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.523 ' CE1' ' HA3' ' A' ' 156' ' ' GLY . 44.5 m-85 -101.18 146.59 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.184 -0.948 . . . . 0.0 109.547 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.838 HD12 ' HB2' ' A' ' 172' ' ' CYS . 7.7 mt -98.67 160.07 28.85 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.109 -0.995 . . . . 0.0 109.404 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 150' ' ' LEU . 35.4 Cg_endo -77.58 -35.5 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.665 2.243 . . . . 0.0 111.81 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.633 ' CD ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -62.94 -46.38 88.02 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.837 -1.164 . . . . 0.0 110.143 -179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.456 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.9 p -120.48 -51.66 2.17 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.454 -176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 112.43 -7.32 26.51 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 25.3 m170 -44.75 136.21 4.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.216 -1.167 . . . . 0.0 107.914 179.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 149' ' ' PHE . . . -112.99 126.48 7.5 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.135 -1.507 . . . . 0.0 110.85 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 39.7 m-85 -125.5 157.47 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.532 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 9.3 m80 -52.37 155.61 2.02 Favored 'General case' 0 C--N 1.288 -2.086 0 O-C-N 121.223 -0.923 . . . . 0.0 110.142 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.458 ' C ' HG12 ' A' ' 162' ' ' VAL . . . -74.46 -26.45 60.05 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -84.12 -53.91 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.946 -0.471 . . . . 0.0 109.881 179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.56 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 13.5 m -62.45 -42.07 99.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.783 -1.198 . . . . 0.0 108.608 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 9.4 p -57.78 -24.55 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.337 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 166' ' ' LEU . 14.4 m-20 -82.77 -45.75 13.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.214 -0.929 . . . . 0.0 109.151 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 31.4 mmm -63.7 -23.12 67.24 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 108.725 179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.701 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 61.6 t-105 -81.66 -22.24 37.64 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.454 -0.779 . . . . 0.0 109.004 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.562 ' O ' ' C ' ' A' ' 167' ' ' GLY . 10.9 mt -51.74 -59.37 4.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.602 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 18.14 61.71 0.01 OUTLIER Glycine 0 N--CA 1.505 3.249 0 N-CA-C 111.596 -0.602 . . . . 0.0 111.596 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.602 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 0.6 OUTLIER 91.33 -53.21 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.751 -0.852 . . . . 0.0 109.266 -179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.536 ' N ' ' O ' ' A' ' 166' ' ' LEU . 14.4 m-70 -71.35 110.68 6.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.904 -1.122 . . . . 0.0 108.771 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.559 ' HA ' HD22 ' A' ' 166' ' ' LEU . 1.0 OUTLIER -99.29 52.11 0.95 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.379 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 178' ' ' THR . 15.5 p -143.6 -176.14 4.84 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 122.072 0.939 . . . . 0.0 110.217 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.838 ' HB2' HD12 ' A' ' 150' ' ' LEU . 9.2 t -68.94 133.62 90.06 Favored Pre-proline 0 C--N 1.297 -1.708 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.701 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 31.6 Cg_endo -74.91 -28.11 9.62 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 121.991 1.794 . . . . 0.0 113.827 -178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 6.6 tp -89.87 -39.8 12.82 Favored 'General case' 0 C--N 1.293 -1.852 0 C-N-CA 117.357 -1.737 . . . . 0.0 111.608 -177.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.73 ' SG ' HD12 ' A' ' 177' ' ' LEU . 14.6 p -106.88 -44.6 4.38 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.711 -1.243 . . . . 0.0 109.268 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.581 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 3.6 mtt85 101.41 36.2 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 122.078 0.942 . . . . 0.0 109.588 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.73 HD12 ' SG ' ' A' ' 175' ' ' CYS . 43.6 mt -94.96 103.66 15.52 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.915 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -42.14 155.17 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.121 -0.987 . . . . 0.0 110.075 -179.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 150' ' ' LEU . 1.5 t -87.54 -49.19 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.0 109.398 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.98 151.11 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.206 -0.934 . . . . 0.0 109.463 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.47 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 1.9 ttt -156.42 69.19 0.62 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.206 -0.934 . . . . 0.0 109.441 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -101.01 116.46 32.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.5 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -77.16 93.54 3.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.407 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.02 -178.65 45.95 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 1.097 ' CG1' HD12 ' A' ' 141' ' ' LEU . 40.0 t -89.24 95.95 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.301 -1.117 . . . . 0.0 109.479 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -135.06 120.1 18.69 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.269 -0.895 . . . . 0.0 110.388 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.71 111.11 4.63 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.684 ' HB2' HD13 ' A' ' 174' ' ' LEU . . . -66.95 -3.33 6.8 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.405 -0.809 . . . . 0.0 111.116 -177.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 8.5 t -81.97 -64.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.815 -1.178 . . . . 0.0 109.612 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 138' ' ' LEU . 20.1 p -94.77 -28.0 15.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.167 -0.958 . . . . 0.0 109.591 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.487 ' CB ' ' O ' ' A' ' 137' ' ' CYS . 3.2 mt 78.1 41.55 0.12 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.564 -0.71 . . . . 0.0 109.361 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.65 152.92 31.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.194 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -67.44 155.62 38.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.164 -0.96 . . . . 0.0 109.664 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 1.097 HD12 ' CG1' ' A' ' 132' ' ' VAL . 43.1 mt -94.17 98.2 10.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.155 -0.966 . . . . 0.0 109.355 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -116.9 172.86 6.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.613 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -54.57 166.17 0.49 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.262 -0.899 . . . . 0.0 109.464 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 83.52 0.12 89.84 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -129.68 167.58 17.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.141 -1.211 . . . . 0.0 109.513 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.831 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 81.3 mm-40 -132.61 80.09 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.295 -0.878 . . . . 0.0 109.321 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.89 ' HB2' HD22 ' A' ' 141' ' ' LEU . . . -72.34 140.12 48.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.173 -0.955 . . . . 0.0 109.577 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HD3' HG11 ' A' ' 162' ' ' VAL . 22.4 mtp85 -108.81 122.11 46.47 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.442 -0.786 . . . . 0.0 109.635 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' C ' HD23 ' A' ' 150' ' ' LEU . 1.7 m-85 -97.23 147.0 24.56 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.85 HD12 ' HB2' ' A' ' 172' ' ' CYS . 10.2 mt -98.11 147.23 32.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.571 -1.33 . . . . 0.0 109.963 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.62 0.63 9.79 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 111.157 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.609 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -93.05 -46.64 7.36 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 122.26 1.028 . . . . 0.0 110.111 -179.298 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.466 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.06 -48.95 2.32 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.533 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 114.18 4.32 22.36 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.626 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 25.8 m170 -62.74 118.26 7.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . -93.83 124.22 7.76 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.464 -178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.631 ' CE1' ' HG2' ' A' ' 173' ' ' PRO . 89.5 m-85 -120.09 -171.64 2.19 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 147' ' ' ALA . 4.9 m80 -92.11 159.0 15.89 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.077 -1.014 . . . . 0.0 109.974 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.831 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -73.68 -28.21 61.63 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 177.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -84.38 -52.31 6.28 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.013 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.578 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 18.9 m -64.63 -40.32 95.26 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.826 -1.172 . . . . 0.0 109.082 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 158' ' ' HIS . 4.4 p -62.34 -35.65 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.539 -0.725 . . . . 0.0 109.696 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.855 ' HA ' HD12 ' A' ' 166' ' ' LEU . 11.8 m-20 -71.02 -50.78 30.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.185 -0.947 . . . . 0.0 109.665 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 17.8 mmt -64.79 -23.25 67.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 108.813 179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 43.1 t-105 -79.0 -20.35 49.3 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.491 -0.755 . . . . 0.0 109.164 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.964 HD23 ' O ' ' A' ' 169' ' ' HIS . 11.0 mt -77.66 -74.17 0.27 Allowed 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.379 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.627 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 30.05 32.86 0.01 OUTLIER Glycine 0 N--CA 1.503 3.107 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.627 ' CB ' ' O ' ' A' ' 167' ' ' GLY . 2.9 t 144.02 -58.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.964 ' O ' HD23 ' A' ' 166' ' ' LEU . 11.4 m170 -72.13 111.57 7.47 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.872 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -96.37 42.52 1.09 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.877 HG22 ' HA ' ' A' ' 178' ' ' THR . 71.9 p -134.0 -178.37 4.99 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-O 122.0 0.905 . . . . 0.0 110.218 -178.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.85 ' HB2' HD12 ' A' ' 150' ' ' LEU . 49.4 t -71.42 135.23 84.23 Favored Pre-proline 0 C--N 1.298 -1.632 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 28.9 Cg_endo -73.15 -22.84 18.75 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.227 1.952 . . . . 0.0 113.598 -178.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.684 HD13 ' HB2' ' A' ' 135' ' ' ALA . 13.0 tp -96.45 -40.26 9.17 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 116.997 -1.881 . . . . 0.0 111.464 -177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.691 ' SG ' HD12 ' A' ' 177' ' ' LEU . 18.9 p -106.81 -45.16 4.26 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.653 -1.28 . . . . 0.0 108.752 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 73.5 mtm180 100.29 32.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.063 0.459 . . . . 0.0 111.229 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' SG ' ' A' ' 175' ' ' CYS . 9.1 mt -82.56 94.23 7.46 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 177.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.877 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -44.9 142.04 1.95 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.833 -1.167 . . . . 0.0 109.36 -179.118 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -107.91 -5.78 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.74 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.43 121.54 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.164 -0.96 . . . . 0.0 109.491 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.475 -179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 128' ' ' MET . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.452 ' O ' ' O ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER 47.44 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.483 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.439 ' OD2' ' OE2' ' A' ' 133' ' ' GLU . 1.7 m-20 -58.79 112.43 1.64 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.282 -0.886 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.43 ' OD2' ' SD ' ' A' ' 128' ' ' MET . 4.2 m-20 -98.52 40.53 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.453 ' O ' ' OE1' ' A' ' 133' ' ' GLU . . . 118.77 -151.9 17.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.96 140.88 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -1.179 . . . . 0.0 109.371 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 131' ' ' GLY . 0.3 OUTLIER -112.1 142.23 44.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.943 . . . . 0.0 110.194 -179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -77.76 110.78 12.92 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.84 -8.52 15.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.142 -0.974 . . . . 0.0 109.975 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.561 ' CG1' ' HB3' ' A' ' 161' ' ' CYS . 87.9 t -98.69 -66.47 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.991 -1.068 . . . . 0.0 110.533 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 12.2 p -93.58 -17.9 22.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.666 -1.271 . . . . 0.0 109.956 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.9 mt 60.3 41.3 16.62 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' O ' ' C ' ' A' ' 140' ' ' GLU . . . -105.62 127.89 53.31 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.861 . . . . 0.0 109.371 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 139' ' ' ALA . 1.9 mt-10 -45.3 118.17 1.63 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.26 -0.9 . . . . 0.0 109.139 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.434 HD22 ' HB2' ' A' ' 147' ' ' ALA . 9.3 mt -58.26 101.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.203 -0.936 . . . . 0.0 109.399 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -114.98 172.47 7.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.231 -0.918 . . . . 0.0 109.443 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -65.65 150.9 47.69 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 110.14 -21.39 24.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -107.81 173.73 6.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -1.161 . . . . 0.0 109.456 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 4.5 mm-40 -126.71 88.02 2.76 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.125 -0.984 . . . . 0.0 109.627 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 148' ' ' ARG . . . -68.15 176.95 2.44 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 109.392 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 147' ' ' ALA . 0.7 OUTLIER -149.43 122.49 8.85 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.352 -0.842 . . . . 0.0 109.08 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.473 ' N ' ' CD1' ' A' ' 149' ' ' PHE . 16.2 m-85 -100.91 146.24 27.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.928 . . . . 0.0 108.926 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.879 HD12 ' HB2' ' A' ' 172' ' ' CYS . 11.7 mt -97.03 154.89 38.04 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 120.923 -1.111 . . . . 0.0 109.522 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.87 -2.12 12.26 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.721 2.281 . . . . 0.0 110.813 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.626 ' HD3' ' HB3' ' A' ' 177' ' ' LEU . 6.1 mtp180 -93.37 -47.26 6.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.2 -0.937 . . . . 0.0 110.522 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.478 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.7 p -120.99 -51.85 2.11 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.106 -177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.41 -0.94 18.64 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 157' ' ' PHE . 29.3 m170 -58.65 125.0 21.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.088 -1.242 . . . . 0.0 107.704 179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 148' ' ' ARG . . . -102.44 126.61 8.93 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.925 -178.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 155' ' ' HIS . 45.4 m-85 -125.64 151.98 45.8 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 178.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.541 ' O ' ' CG1' ' A' ' 162' ' ' VAL . 10.0 m80 -49.0 157.25 0.43 Allowed 'General case' 0 C--N 1.287 -2.147 0 O-C-N 121.262 -0.899 . . . . 0.0 110.473 -179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.616 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -76.22 -26.51 56.15 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -83.79 -53.37 5.66 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.561 ' HB3' ' CG1' ' A' ' 136' ' ' VAL . 11.3 m -63.85 -41.21 97.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.852 -1.155 . . . . 0.0 108.82 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.541 ' CG1' ' O ' ' A' ' 158' ' ' HIS . 5.3 p -61.92 -29.26 45.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 119.686 -0.805 . . . . 0.0 109.728 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.638 ' HA ' HD12 ' A' ' 166' ' ' LEU . 49.3 m-20 -76.55 -48.4 19.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.164 -0.96 . . . . 0.0 109.582 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 14.4 mtm -65.48 -23.38 66.89 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -0.969 . . . . 0.0 108.513 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 51.6 t-105 -77.68 -20.56 53.48 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.551 -0.718 . . . . 0.0 109.174 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.808 HD23 ' O ' ' A' ' 169' ' ' HIS . 31.7 mt -74.06 -73.39 0.23 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.648 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 22.83 38.5 0.01 OUTLIER Glycine 0 N--CA 1.505 3.256 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.651 ' N ' ' O ' ' A' ' 166' ' ' LEU . 3.7 m 139.54 -62.51 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.808 ' O ' HD23 ' A' ' 166' ' ' LEU . 54.6 m170 -71.99 111.42 7.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.593 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 180' ' ' VAL . 0.0 OUTLIER -95.03 36.15 1.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 178' ' ' THR . 40.2 p -125.46 -178.69 4.32 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-O 122.111 0.958 . . . . 0.0 110.129 -178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.879 ' HB2' HD12 ' A' ' 150' ' ' LEU . 42.0 t -71.99 136.24 82.43 Favored Pre-proline 0 C--N 1.297 -1.699 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 30.6 Cg_endo -74.33 -20.26 18.73 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 122.003 1.802 . . . . 0.0 113.352 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 23.9 tp -97.69 -40.58 8.51 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 116.996 -1.882 . . . . 0.0 111.376 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.612 ' SG ' HD12 ' A' ' 177' ' ' LEU . 19.4 p -107.11 -44.88 4.27 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.591 -1.318 . . . . 0.0 108.655 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.595 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 69.2 mtp180 100.24 29.82 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 120.941 0.401 . . . . 0.0 111.235 177.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.626 ' HB3' ' HD3' ' A' ' 152' ' ' ARG . 10.3 mt -78.0 92.46 4.34 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.817 ' HA ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -44.61 146.23 0.77 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.898 -1.126 . . . . 0.0 109.771 -179.084 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.444 HG22 ' HD2' ' A' ' 152' ' ' ARG . 0.8 OUTLIER -114.51 -15.79 9.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.606 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 170' ' ' SER . 0.1 OUTLIER -109.87 109.64 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.281 -0.887 . . . . 0.0 109.469 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.438 179.995 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 67.84 123.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.52 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -82.7 114.37 21.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 130' ' ' ASP . 21.5 t0 -126.24 133.92 51.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.907 . . . . 0.0 109.54 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.12 -49.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.8 t -95.91 137.23 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -128.51 141.28 51.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.152 -0.967 . . . . 0.0 110.169 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 16.9 t -74.61 112.21 10.57 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.06 -8.47 30.62 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.062 -1.023 . . . . 0.0 109.472 -179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.576 ' HB ' ' HB3' ' A' ' 161' ' ' CYS . 93.2 t -98.85 -66.25 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.134 -0.979 . . . . 0.0 110.637 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.472 ' SG ' ' CB ' ' A' ' 139' ' ' ALA . 11.2 p -94.37 -13.58 26.19 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.683 -1.26 . . . . 0.0 110.122 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.5 mt 56.76 40.21 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.087 -1.008 . . . . 0.0 109.145 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.472 ' CB ' ' SG ' ' A' ' 137' ' ' CYS . . . -103.87 126.49 51.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.463 -0.773 . . . . 0.0 109.449 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 139' ' ' ALA . 18.0 mt-10 -45.62 115.06 0.86 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 109.425 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.493 HD23 ' NE2' ' A' ' 158' ' ' HIS . 49.9 mt -58.28 96.99 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 109.595 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -98.32 174.95 6.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.875 . . . . 0.0 109.357 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -71.51 155.82 40.14 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.261 -0.899 . . . . 0.0 109.492 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 91.76 23.85 27.09 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -134.53 168.98 17.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -1.156 . . . . 0.0 109.58 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.81 ' O ' ' HB2' ' A' ' 159' ' ' ALA . 7.6 mp0 -120.27 76.3 1.17 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.032 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' A' ' 157' ' ' PHE . . . -76.94 143.51 39.46 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.185 -0.947 . . . . 0.0 110.004 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.672 ' HD2' HG11 ' A' ' 162' ' ' VAL . 60.6 mtt180 -108.8 122.41 47.12 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.385 -0.822 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' CE2' ' HA3' ' A' ' 156' ' ' GLY . 18.8 m-85 -101.11 147.05 26.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.368 -0.832 . . . . 0.0 109.051 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.87 HD12 ' HB2' ' A' ' 172' ' ' CYS . 8.8 mt -103.0 157.83 32.95 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.759 -1.213 . . . . 0.0 109.959 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.93 ' CD ' HG13 ' A' ' 179' ' ' VAL . 36.4 Cg_endo -78.64 -43.67 0.16 Allowed 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.994 2.463 . . . . 0.0 112.154 -178.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.679 HH21 HG23 ' A' ' 178' ' ' THR . 0.0 OUTLIER -52.26 -45.73 65.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.785 -1.197 . . . . 0.0 110.424 -178.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 177' ' ' LEU . 1.8 p -120.79 -51.94 2.13 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.725 -0.609 . . . . 0.0 111.733 -176.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 150' ' ' LEU . . . 111.13 1.75 28.24 Favored Glycine 0 N--CA 1.484 1.868 0 N-CA-C 108.702 -1.759 . . . . 0.0 108.702 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.63 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 24.1 m170 -54.49 119.65 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.56 ' HA3' ' CE2' ' A' ' 149' ' ' PHE . . . -95.1 123.89 7.77 Favored Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.571 -178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.641 ' O ' ' HB1' ' A' ' 147' ' ' ALA . 83.2 m-85 -118.96 -170.66 1.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.555 ' O ' HG12 ' A' ' 162' ' ' VAL . 4.8 m80 -92.23 159.62 15.54 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.04 -1.037 . . . . 0.0 109.91 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.81 ' HB2' ' O ' ' A' ' 146' ' ' GLU . . . -74.49 -27.79 60.72 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -84.09 -52.17 6.5 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.965 -0.46 . . . . 0.0 109.888 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.576 ' HB3' ' HB ' ' A' ' 136' ' ' VAL . 11.3 m -65.56 -41.5 92.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.873 -1.142 . . . . 0.0 109.147 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.672 HG11 ' HD2' ' A' ' 148' ' ' ARG . 3.9 p -61.96 -34.2 61.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.361 -0.837 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.593 ' HA ' HD12 ' A' ' 166' ' ' LEU . 24.1 m-20 -71.24 -50.93 27.73 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.196 -0.94 . . . . 0.0 109.7 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 1.8 mtt -64.56 -23.51 67.29 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.388 -0.82 . . . . 0.0 108.97 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' TRP . . . . . 0.734 ' CD1' ' HB3' ' A' ' 173' ' ' PRO . 45.9 t-105 -78.89 -20.44 49.44 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.477 -0.764 . . . . 0.0 109.223 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.896 HD23 ' O ' ' A' ' 169' ' ' HIS . 38.6 mt -74.63 -73.62 0.23 Allowed 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.636 ' O ' ' CB ' ' A' ' 168' ' ' SER . . . 26.83 34.67 0.01 OUTLIER Glycine 0 N--CA 1.503 3.118 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 166' ' ' LEU . 6.7 p 143.0 -60.74 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.896 ' O ' HD23 ' A' ' 166' ' ' LEU . 15.0 m-70 -72.2 111.32 7.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.883 . . . . 0.0 109.405 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 166' ' ' LEU . 0.7 OUTLIER -94.46 48.91 1.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.823 HG22 ' HB ' ' A' ' 178' ' ' THR . 39.7 p -143.48 -177.04 5.19 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.181 0.991 . . . . 0.0 110.657 -178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' CYS . . . . . 0.87 ' HB2' HD12 ' A' ' 150' ' ' LEU . 19.5 t -70.28 134.71 86.94 Favored Pre-proline 0 N--CA 1.49 1.539 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.734 ' HB3' ' CD1' ' A' ' 165' ' ' TRP . 29.5 Cg_endo -73.91 -27.77 11.91 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.181 1.921 . . . . 0.0 113.794 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 11.4 tp -91.12 -40.03 11.82 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 117.198 -1.801 . . . . 0.0 111.601 -177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.731 ' SG ' HD12 ' A' ' 177' ' ' LEU . 15.6 p -107.03 -45.31 4.18 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.669 -1.269 . . . . 0.0 109.13 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ARG . . . . . 0.579 ' CB ' ' O ' ' A' ' 175' ' ' CYS . 54.4 mtt180 101.88 36.17 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 CA-C-O 122.059 0.933 . . . . 0.0 109.6 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.731 HD12 ' SG ' ' A' ' 175' ' ' CYS . 38.4 mt -91.97 94.47 9.3 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.823 ' HB ' HG22 ' A' ' 171' ' ' THR . 0.1 OUTLIER -41.95 154.68 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.193 -0.942 . . . . 0.0 110.199 -179.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.93 HG13 ' CD ' ' A' ' 151' ' ' PRO . 2.5 t -98.49 -26.63 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.269 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 2.7 m -93.87 146.43 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.26 -0.9 . . . . 0.0 109.31 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 181' ' ' VAL . 53.2 t . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_